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ABSTRACT OF THE DISSERTATION 
 
Natural Killer Cell Recruitment and Activation Following Orthopoxviral Infection 
 
by 
 
Melissa A. Pak-Wittel 
 
Doctor of Philosophy in Biology and Biomedical Sciences 
Immunology 
 
Washington University in St Louis, 2012 
 
Professor Wayne M. Yokoyama, Chairperson 
 
The orthopoxviridae are large, complex DNA viruses with important historical 
and clinical significance. Members of this genus encode numerous proteins known to 
subvert the immune response to infection, providing a useful system to probe required 
host responses for resistance and survival. Natural killer (NK) cells provide an essential 
innate response to infection through direct lysis of infected cells and cytokine production. 
The innate anti-viral response following infection is associated with NK cell population 
expansion in draining LNs, where they are normally a rare population. We have 
identified mechanisms underlying NK cell expansion following orthopoxviral infection 
and have examined viral inhibition of the NK cell-mediated host response. 
 Since close contact with cowpox virus (CPXV), a natural pathogen of rodents, 
causes zoonotic infections in humans, we employed a footpad model of infection in mice 
to determine the requirement of NK cells for resistance to orthopoxviral infection. 
Systemic depletion of NK cells prior to CPXV infection resulted in increased viral 
replication and systemic dissemination. Recruitment of NK cells to the draining LN was 
pertussis toxin sensitive indicating chemokine receptor dependence. Candidate 
chemokine receptors were identified by comprehensive analysis of chemokine mRNA 
 xi 
expression in the draining LN in conjunction with chemokine receptor expression on NK 
cells. We determined that CXCR3 was intrinsically required for NK cell recruitment to 
the draining LN in an interferon-!# (IFN-!) dependent manner. Additionally, a non-
overlapping requirement for subcapsular sinus macrophages was required for NK cell 
recruitment. 
 CPXV inhibited full maturation of NK cells leading to incomplete activation 
following infection. We found that NK cells recruited to the draining LN did not produce 
IFN-! or up-regulate surface activation markers. The inhibition of NK cell production of 
IFN-! was CPXV specific, multifactorial and complex. Despite this phenotype, cytotoxic 
function of NK cells was preserved through uninhibited production of granzyme B. We 
have demonstrated that the innate response to CPXV infection induces chemokine-
mediated recruitment of NK cells to the draining LN where they limit replication and 
dissemination despite specific inhibition by CPXV.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1: 
Introduction 
 2 
Orthopoxviruses, Cross Protective Vaccination and Zoonotic Infections 
Orthopoxviruses are large, complex DNA viruses whose genus includes 
historically and clinically important viruses. Among these is variola virus (VARV), the 
causative agent of smallpox infection, which had devastating consequences on the human 
population due to its significant morbidity and morality (1). Cross-protection conferred 
by another orthopoxvirus, vaccinia virus (VV), allowed eradication of naturally occurring 
smallpox disease during a campaign led by the World Health Organization. The basis of 
cross-protection was demonstrated by Edward Jenner who deliberately inoculated an 
eight year old boy first with freshly isolated cowpox virus (CPXV) from a lesion on a 
dairy maid and subsequently with VARV (2). Jenner’s hypothesis that immunization with 
CPXV would confer protection to smallpox challenge was confirmed when the child 
displayed no signs of smallpox disease. 
Despite eradication of natural smallpox infection, the possibility of deliberate 
release of VARV during a potential bioterrorist event remains. Additionally, other 
orthopoxviruses increasingly cause emerging zoonotic infection including monkeypox 
virus, which is primarily localized to Africa but caused a recent outbreak in the 
Midwestern United States (3-5). There have also been increasing reports of zoonotic 
CPXV infection in Europe, where CPXV is endemic in the rodent population (6-10). 
Despite reports of increasing zoonotic infections, vaccination is no longer routinely 
recommended or practiced. While most immunocompetent individuals tolerate 
vaccination with little to no problem, significant side effects have been reported in 
patients who are immunocompromised and those with eczema and atopic dermatitis (9, 
11). In addition, the protective immune response diminishes over time in vaccinated 
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individuals (12-14). This has resulted in a population that is increasingly susceptible to 
zoonotic orthopoxvirus infections.  
The origin of VV is unknown, although there is some speculation that VV arose 
following multiple passages of CPXV during the course of smallpox eradication (15). 
Due to the widespread propagation of VV strains that were ultimately used to eradicate 
smallpox, VV became the prototypical orthopoxvirus for study of immunomodulation 
and host-pathogen interactions (16). Some studies have examined immune evasion by 
VV with the goal of generating safer vaccines. These studies have resulted in the 
development of attenuated vaccine strains including ACAM200 and modified vaccinia 
Ankara (MVA), which were derived from serial in vitro passaging and targeted deletions 
of immunomodulatory genes, respectively (17, 18). Since VV also elicits a strong cellular 
and humoral immune response, other studies have examined its use as a vector to bolster 
immunizations against other pathogens (18). These studies have demonstrated that VV-
vectored immunization increases the immune response to cancer antigens and several 
pathogens including human immunodeficiency virus and rabies virus. Thus, many studies 
have both examined immunomodulation of the host immune system and exploited the 
immunostimulatory response by VV. 
Increasing numbers of reports indicate that zoonotic CPXV infections are 
predominantly caused by skin scratch inoculation following interaction with an infected 
animal (6-9) whereas zoonotic infection with VV very rarely occurs, especially as the 
host reservoir is unknown (19). CPXV has the largest genome in the Orthopoxvirus genus 
and its host reservoir is the wild rodent population in Europe (10, 20-22). Since CPXV 
and the mouse have co-evolved, this makes host-pathogen interplay relevant to study in a 
mouse model. Another area of interest for research into CPXV biology is examination of 
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the large arsenal of potential host range and immunomodulatory open reading frames 
(ORFs) encoded by CPXV. Analysis of CPXV unique ORFs may highlight particularly 
important host immune responses for resistance to orthopoxviruses that cannot be studied 
using other orthopoxvirus genus members. Therefore, continued study of primary 
immune responses to orthopoxviruses in a matched host-pathogen relationship, such as 
mouse-CPXV, is of interest to provide additional insight into the host immune response 
which may lead to novel clinical advances to protect against emerging orthopoxvirus 
infections. 
 
Viral Immune Evasion 
 Orthopoxvirus genome size varies greatly, from 130kb to 290kb, and many ORFs 
are highly conserved between genus members. The central coding region, encoding ORFs 
responsible for viral replication and life cycle, is highly conserved among all 
orthopoxvirus family members (22). The genetic termini are more variable among 
orthopoxviruses, and are where ORFs involved in host range and immunomodulation are 
located. Orthopoxviruses contain many virally encoded proteins that act in combination 
to subvert both intracellular and extracellular host immune responses (23, 24).  
Intracellular inhibition by orthopoxviruses occurs through numerous viral proteins 
acting at different levels of respective anti-viral signaling pathways. Host recognition of 
orthopoxvirus infection is mediated by pattern recognition receptors (PRRs) such as toll-
like receptors, NOD-like receptors and intracellular RNA sensors, including retinoic acid 
inducible receptors (RIG-I) and melanoma differentiation associated gene-5 (MDA5) 
(24-27). Orthopoxviruses encode inhibitory proteins that sequester double stranded RNA 
to evade recognition by RIG-I and MDA5. Also, numerous virally encoded proteins 
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interfere with signaling cascades downstream of PRRs to prevent host recognition. These 
mechanisms of inhibition have been well characterized and virally encoded regulators 
have been identified at most levels of signaling pathways (16, 23). In addition to 
inhibiting signaling pathways downstream of host recognition by PRR, several inhibitory 
proteins produced by orthopoxviruses have dual functions in inhibiting apoptotic 
signaling pathways (28). Orthopoxviruses also encode intracellular inhibitory proteins 
that prevent surface expression of major histocompatibility complex class I (MHC class 
I) to escape detection by the cytotoxic CD8+ T cell response (29-32). Thus, 
orthopoxviruses encode numerous intracellular immune evasion proteins that interfere 
with multiple host responses. 
Orthopoxvirus mediated control of the host response also occurs extracellularly 
through a number of mechanisms. These include expression of virally encoded binding 
proteins for cytokines, chemokines and complement proteins to inhibit the recruitment of 
lymphocytes and thus progression of the inflammatory response. There are numerous 
cytokines that orthopoxviruses target to prevent inflammation including type I interferons 
(IFNs), IFN-!, tumor necrosis factor " (TNF-"), IL-1 and IL-18, with some 
orthopoxviruses encoding more than one ORF to target each cytokine (23, 33-35). 
Orthopoxviruses interfere with chemokine signaling and recruitment by encoding both 
chemokine binding proteins and proteins that can bind to and saturate 
glycosoaminoglycans on host surfaces where chemokines normally bind following 
secretion (36-38). Modulation of the inflammatory immune response by orthopoxviruses 
includes the induction of anti-inflammatory cytokines like IL-10 (39). Due to constant 
selective pressure from co-evolution with their hosts, orthopoxviruses have developed a 
number of strategies to subvert the host immune response. 
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Host Response to Orthopoxvirus Infection 
 Despite numerous immunomodulatory proteins encoded by orthopoxviruses, in 
general, a strong humoral and cellular immune response is elicited following infection, 
conferring lasting immunity including cross-species protection (14, 17, 40). Infection 
with orthopoxviruses leads to the generation of neutralizing antibodies against both the 
intracellular mature virion and the extracellular enveloped virus resulting in a long-
lasting antibody-mediated protection. Generation of neutralizing antibodies requires 
CD4+ T cells and is first detectable 14 days following vaccination and persists for 
decades. In the absence of B cells, but not CD4+ or CD8+ T cells, naïve hosts challenged 
with orthopoxvirus succumb to infection indicating that an antibody response is essential 
for survival. Although T cell responses are not required for survival, they prevent viral 
replication and spread immediately following inoculation (17). In contrast to CD8+ T 
cells, whose function peaks 2 to 4 weeks post vaccination before primary responses 
decline, the CD4+ T cell response is long lived (14, 40). Prophylactic treatment of naïve 
Rhesus macaques with human vaccinia immunoglobulin from vaccinated individuals is 
protective, even in the absence of memory CD4+ or CD8+ T cell responses (14). On the 
other hand, in the absence of B cells, CD4+ and CD8+ memory T cells can confer 
protection to VV(40). These strong cellular and humoral responses confer both resistance 
and long-lived cross-species protection against orthopoxvirus infection. 
 In addition to the requirement for a strong adaptive immune response, many 
elements of the innate immune system have been implicated in resistance to 
orthopoxvirus infection. These include induction of pro-inflammatory cytokines such as 
IL-12 and IL-18 that mediate TH1 skewed adaptive immune priming and activation of 
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both NK cells and T cells (41, 42). Additionally, mice infected with VV that ectopically 
expresses IL-15 survive infection through the activation of NK cells (43). Dendritic cells 
(DCs) can sense infection through PRRs and secrete IL-12, IL-15 and IL-18 which 
stimulate activation of NK cells (44, 45). Despite several in vitro studies demonstrating 
inhibition of maturation and induction of apoptosis in DCs upon orthopoxvirus infection, 
in vivo infection results in up-regulation of co-stimuatory molecules and production of 
IL-12 (46-48). However, a requirement for DCs to mediate protection from orthopoxvirus 
infection has not been demonstrated in vivo. Similarly to orthopoxvirus infection of DCs, 
in vitro infection of macrophages results in apoptosis. However, in vivo macrophage 
depletion in an intranasal model of infection results in increased susceptibility (49, 50). 
These in vivo studies indicate that DCs and macrophages confer protection against 
orthopoxvirus infection. Thus redundancy in host immune responses to orthopoxvirus 
infection confers resistance and protection.  
 
Natural Killer Cells 
Natural killer (NK) cells are innate immune lymphocytes that play an important 
role in the response to tumors and infections by inducing lysis of transformed or infected 
cells and producing cytokines that help shape other immune responses. Activation of NK 
cell function is mediated through two distinct mechanisms: integration of signaling 
through inhibitory and activating receptors (51, 52) and cytokine stimulation (45, 53, 54). 
Down-regulation of MHC class I, which normally mediates strong inhibitory signaling in 
uninfected cells, renders cells sensitive to NK cell lysis (55). Ligands for activation 
receptors can either be pathogen-derived or host-derived and up-regulated upon cell 
stress (56, 57). While stimulation with cytokines, such as IL-12, IL-15 and IL-18, has 
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been shown to be effective at activating NK cells to produce other cytokines, NK cell 
effector functions are largely determined locally since cell-cell contact is required for NK 
cell-mediated lysis of infected cells. Ultimately, it is the integration of these signals that 
determines NK cell functionality. 
Following activation, NK cells function by lysing target cells or secreting 
cytokines. Lysis of virally infected cells is mediated through granzyme B and perforin 
(58, 59). Activation of NK cells through cytokine signaling or activation receptor 
engagement results in cytokine production by NK cells including IFN-!, TNF-" and 
granulocyte-macrophage stimulating colony factor (GMCSF) (60-62). Following 
stimulation, NK cells produce pro-inflammatory chemokines, including CCL3, CCL4 and 
CCL5, that recruit macrophages and other lymphocytes to the site of inflammation (63, 
64). These coordinated actions of NK cells limit viral replication, induce inflammation 
and prime an adaptive immune response at early times following infection. 
 
Chemokines and Chemokine Receptors 
 The immune response is marked by recruitment of innate and adaptive 
lymphocytes to the site of infection or inflammation and to secondary lymphoid organs. 
Recruitment of lymphocytes is mediated through multiple mechanisms, but one of the 
best characterized is chemokine-mediated trafficking. Chemokines have conserved 
cysteine residues and from which their nomenclature is derived (65). Some of these 
molecules are constitutively expressed, as is the case for CCL19 and CCL21 which 
recruit T and B cells into secondary lymphoid organs through high endothelial venues 
(66). During inflammation, there is induction of inflammatory chemokine expression that 
is responsible for recruiting innate and adaptive lymphocytes to the site of infection or 
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inflammation (67, 68). There is some suggestion that chemokines act not only in 
recruitment but also possess direct antimicrobial activity (69). Once chemokines are 
secreted, they bind to surface expressed glycosaminoglycans. Promiscuous binding 
occurs between inflammatory chemokines and their receptors, suggesting a need for 
redundancy in this recruitment system.  
Chemokine receptors are G protein-coupled receptors (GPCRs) that contain seven 
transmembrane spanning regions (65, 70). As with other GPCRs, chemokine receptors 
signal via guanine nucleotide-binding proteins (G proteins) which become active when 
GDP is exchanged for GTP, activating downstream signaling cascades (70). It is well 
known that pertussis toxin blocks GPCRs by ribosylating the GDP on the G protein, 
locking it in an inactive state and preventing downstream signaling (71). Lymphocytes 
express an array of chemokine receptors, allowing trafficking during development, 
homeostatic conditions and to sites of inflammation. 
The recruitment of NK cells in homeostatic and inflammatory conditions has been 
well studied in human systems, but many discrepancies exist in the murine model (72-
74). Since infection with different pathogens stimulates and/or inhibits the production of 
different chemokines, NK cells must require the expression of several chemokine 
receptors for proper localization to control infection (75-79). However, many of these 
studies do not address murine pathogens, so conclusions about murine NK cell 
chemokine receptor requirements remain somewhat unclear. 
 
A Protective Role for NK Cells Following Orthopoxvirus Infections 
 Our understanding of NK cells and their requirement for orthopoxvirus resistance 
is in the context of VV and ectromelia virus (ECTV) infection, although the endemic 
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hosts for these viruses remains obscure. In systems where NK cells are lacking, such as in 
genetic deficiency or following systemic antibody depletion, viral infection is 
uncontrolled and results in lethality (80-82). During ECTV infections, the NK cell 
receptors, CD94 and NKG2D, are required for protection and NK cells producing IFN-! 
and granzyme B expand in the draining lymph node (81, 83). Additionally, the transfer of 
Thy1+ memory NK cells is protective against lethal challenge with VV infection (84). 
These data indicate that NK cells are an important component of innate immunity-
mediated resistance to ECTV and VV. 
Since CPXV has co-evolved with its rodent hosts, CPXV infection of rodents is 
appropriate for the study of orthopoxvirus-host interactions. However, the role of NK 
cells in CPXV infection has not been investigated. CPXV has the largest genome in the 
orthopoxvirus genus (20) and contains several ORFs not found in either VV or ECTV 
genomes. This includes two ORFs, CPXV012 and CPXV203, that potently down-
regulate the expression of MHC class I (29-32).While this might render the infected cell 
sensitive to NK cell-mediated lysis, CPXV also encodes another ORF, CPXV018, that 
binds in vitro with high affinity to the NKG2D activation receptor and blocks its 
recognition of ligands on target cells (85). Additionally, all orthopoxviruses encode a 
number of cytokine binding proteins which could also limit the activation of NK cells, 
such as one specifically targeting IL-18 (34), a well known mediator of NK cell 
activation. NK cell activation could also be non-specifically subverted through virally 
encoded chemokine binding proteins that may limit lymphocyte recruitment, including 
NK cells, to the site of infection (38, 86, 87). Thus the role of NK cells following CPXV 
infection was unclear. 
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In these studies, we developed a model of footpad inoculation using CPXV 
infection and demonstrated that it mimics the natural route of viral transmission both 
within the host population to zoonotic hosts. Using this model of inoculation, we 
determined that NK cells were required in response to CPXV infection. Furthermore, we 
investigated the mechanisms of NK cell recruitment to the draining LN following CPXV 
infection including examination of chemokine-mediated trafficking and up-stream 
signaling requirements. While NK cells were required for resistance to CPXV infection, 
we also observed that CPXV was inhibiting their function and further examined this 
inhibition by using CPXV deletion-mutant viruses in our footpad infection model. These 
studies extend the requirement of NK cells to CPXV infection and additionally provide 
novel insights into NK cell trafficking and stimulation following orthopoxvirus infection. 
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CHAPTER 2: 
Materials and Methods 
 13 
Mice 
Mice were maintained according to institutional guidelines under specific pathogen free 
conditions. C57BL/6Ncr (CD45.1) mice and B6.LY5.2/Cr (CD45.2) mice were obtained 
from the National Cancer Institute (Fredrick, MD). CCR7-/-, CXCR3-/-, CCR2-/-, IFN!R-/- 
and CD11c-DTR transgenic mice were obtained from Jackson Laboratory (Bar Harbor, 
ME) and bred in our facility. CCR5-/- and C57BL/6 control mice were obtained from 
Taconic (Germantown, NY). Batf3-/- mice were a kind gift from the laboratory of Dr. 
Kenneth Murphy (Washington University, St Louis) and were also previously 
described(88). All mice were used between 6 and 12 weeks of age. 
 
Cells and Viruses 
CV-1 and Vero cells were obtained from the American Tissue Culture Center (ATCC, 
Manassas VA) and maintained in recommended media. BMDCs were generated by 
culturing bone marrow cells with Flt-3 ligand (200ng/mL) for 9 days at 37°C at 5% CO2. 
Cowpox virus strain Brighton Red and Vaccinia virus strain Western Reserve were 
plaque purified three times from laboratory stocks initially obtained from the ATCC on 
CV-1 tissue culture cells. Viral stocks were amplified in Vero cells and isolated following 
cell lysis by centrifugation through 36% sucrose solution. Viral titers of these stocks were 
assessed by standard plaque assays on confluent CV-1 monolayers. 
 
Infection 
Mice under anesthesia were infected in the right rear footpad with 1.5x106 pfu in 25µL 
volume of virus diluted in PBS. At 1, 2, 3, 6 or 9 dpi, LNs, spleen, kidneys, lungs, liver, 
feet, uterus and ovaries were isolated. Organs that were used to determine viral titers 
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were frozen at-80°C until processing and organs that were used to assess viral genome 
copies were frozen at -20°C until DNA extraction. 
 
Flow Cytometry 
For samples analyzed by flow cytometry, LNs and spleens were crushed in R10 (RPMI, 
10% FCS, L-glutamine and pen-strep). When macrophages and DCs were stained, 
spleens and LNs were diced and incubated in liberase TL (Roche, Indianapolis, IN) for 
45 minutes at 37°C in 5% CO2 prior to being crushed. Red blood cells in splenocytes 
were lysed before staining for flow cytometry. For later experiments, prior to 
extracellular staining the cells were stained with cell fixable viabilty dye (eBioscience, 
San Diego, CA). Antibodies used for flow cytometry analysis were purchased from both 
BD Biosciences and ebiosciences: NK1.1 (PK136), NKp46 (29A1.4), CD3 (145-2C11), 
CD19 (1d3), CD11c (HL3), Ly6G (1A8), CD11b (M1/70), F4/80 (BM8), CD45.1 (Ly5.1, 
clone A20), CD45.2 (Ly5.2, clone104), CD49b (DX5), Ly49CIFH (14B11), Ly49AD 
(12A8), NKG2D (CX5), CD94 (18d3), CD62L (MEL-14), CD103 (2E7), CD-69 
(H1.2F3), CD127 (A7R34), Siglec H (551), and Klrg1 (2F1). Surface staining of cells 
was performed on ice in staining buffer (3% FBS, 0.1% NaN3 in PBS) with 2.4G2 (anti-
Fc!RII/III) to prevent non-specific antibody binding. When staining for IFN-! and 
granzyme B, whole LNs or red blood cell lysed splenocytes were first incubation in R10 
containing Brefeldin A (GolgiPlug, BD) for 20-30 minutes at 37°C in 5% CO2 before 
extracellular staining. After surface staining, cells were fixed and permeablized using a 
Cytofix/Cytoperm kit (BD Pharmingen) or Mouse FoxP3 Buffer Set (BD Pharmingen) 
according to manufacturer’s instructions. Antibodies used for intracellular staining were 
IFN#! (XMG1.2), Ki67 (B56), FoxP3 (FJK-16s), and Granzyme B (clone GB-12, 
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caltag). Flow cytometry data were collected on BD FACSCantoTM using FACSDiva 
software (BD) and analyzed using FlowJo software (Tree Star, Ashland, OR). 
 
Viral Titers 
Traditional plaque assays were done using organ lysates generated by beat beading three 
times in 1mL of RPMI. Serial dilutions were plated in duplicate on confluent CV-1 
monolayers grown using minimal FCS. Cells were stained 2dpi using a crystal violet 
solution and plaques were counted. Quantitative PCR was used as a more sensitive 
measurement of viral genome copy numbers. DNA was generated from organs and was 
then amplified using StepOnePlus (Applied Biosystems) in a 10µL volume containing 2x 
Universal PCR Master Mix, No AmpErase UNG (Roche). Quantitative PCR DNA probes 
are non-extendable oligonucleotides labeled with 5’ 6-FAM reporter and 3’ Zen / Iowa 
Black FQ quencher dyes. Primer/probe sets were obtained from IDT DNA and sequences 
are indicated in Table 1. Samples were run in duplicate, genome copy number was 
normalized to $-actin copy number and numerical values obtained were multiplied by 
1000. 
 
Depletion 
To systemically deplete NK cells, 200µg of NK1.1 antibody (PK136) or control antibody 
(mAR) was injected IP 2 days prior to infection. For neutralization of IFN-!, 
250µg/mouse of H22 antibody or control PIP antibody, a kind gift from the Dr. Robert 
Schrieber laboratory (Washington University, St Louis), was injected 2 days prior to 
infection. In the CD11c-DTR mice, of diphtheria toxin (Sigma) diluted in PBS was first 
tested at 20, 10 and 5 ng/g body weight of the mouse to determine a dose that selectively 
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depleted DCs but not NK cells or macrophages in the draining lymph node when injected 
in the leg. For recruitment experiments, 5 ng/g body weight was administered in the hind 
leg 1 day prior to infection. To deplete macrophages, 50µL of commercially available 
liposomes that encapsulated clodronate or PBS were injected in the footpad in the foot 5 
days prior to infection (Encapsula, Nashville, TN). 
 
Chemokine RNA expression 
Draining and non-draining LNs were isolated and RNA was extracted using Trizol 
following the manufacturer’s instructions (Invitrogen, Carlsbad, California). cDNA was 
then generated using 500ng of the isolated RNA using Superscript III Reverse 
Transcriptase according to manufacturer’s protocol (Invitrogen). Quantitative PCR was 
then performed as described for viral genome copies except values were only normalized 
to $-actin and were otherwise unmanipulated. Primer/probe set sequences are indicated in 
Table 1. 
 
Adoptive Transfers 
For adoptive transfer experiments, donor splenocytes were purified from C57BL/6 
CD45.1, CCR7 (CD45.2) or CXCR3 (CD45.2) knockout mice and red-blood cells were 
lysed. For the pertussis toxin or PBS pre-treatment, cells were plated at a density of 
3x107/mL in R10 with either 100ng/mL pertussis toxin or PBS and incubated at 37°C in 
5% CO2 for 2 hours before cells were then washed 4 times with PBS. All transferred cells 
were labeled with 2.5µM CFSE (CellTrace, Invitrogen). The labeling reaction was 
quenched using 10% FCS in RPMI. Cells were then washed twice in PBS, passed 
through a 40µm cell strainer and resuspended in a volume such that animals could be 
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injected IV with 200µL volume. BMDCs were injected either into the top of the foot of 
the mouse in a volume of 20µL or intravenously injected in a volume of 100µL. 
 
Multiplex Gene Expression Analysis 
LNs from CPXV infected mice were isolated, homogenized in QuantiGene sample 
processing buffer (Affymetrix, Santa Clara, CA) and then incubated at 65°C for 30 
minutes before being stored at -80°C. Samples were further processed and run using a 
custom multiplex set of beads (Affymetrix) for controls and all listed chemokines by the 
Genome Technology Access Center (Washington University, St Louis, MO). Chemokine 
expression was normalized first to Hprt1 transcripts and fold change was assessed by 
normalizing to the appropriate non-draining LN control. Heat maps were generated using 
Jcolorgrid (UCSF, San Francisco, CA (89)). 
 
Cytokine Bead Array 
Organs were homogenized in 1mL RPMI and supernatants were used in the mouse 
inflammation kit (BD Bioscience) following the manufacturer’s protocol. Data were 
collected using the BD FACSCaliburTM using CellQuest Pro Version 4.0 (Mac, BD 
Biosciences) and BD CBA Version 1.4 (Mac). 
 
Ex Vivo Lymphocyte Stimulation 
Following infection, LNs were harvested and lymphocytes were isolated and incubated 
for 1 hour with with 0.5 !g phorbol myristate acetate (PMA, Sigma-Aldrich) and 4 !g 
ionomycin (Calbiochem) at 37°C in 5% CO2. After 1 hour of incubation, Brefeldin A 
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(GolgiPlug, BD) was added and cells were incubated an additional 7 hours a 37°C in 5% 
CO2 before staining as previously described.   
 
Immunohistochemistry 
LNs were harvested directly into PLP (0.05 M lysine phosphate buffer, pH 7.4, 0.05 % 
glutaraldehyde, 0.002 mg NaIO4 ml21, 0.5 % paraformaldehyde) with 0.1% Triton X-
100 fixative for at least 8 hours then dehydrated in 30% sucrose overnight. Tissues were 
then embedded in OCT in Tissue-Tek (Sakura Finetek) and snap frozen in 2-
methylbutane cooled over dry ice before being stored at -80C until use. Cryostat sections 
were cut 9µm thick before being rehydrated in PBS and blocked with 10% goat serum in 
2.4G2 for 30 minutes. Sections were incubated with primary stain for 2 hours at room 
temperature, washed 3 times, and incubated in secondary stain for 1.5-2 hours. Primary 
antibodies used were anti-CD3 (FITC) and unconjugated anti-CD169 (AbD Serotec) and 
secondary antibody AlexaFluor594 (Molecular Probes). Sections were washed 3 more 
times in PBS and mounted in VectaShield mounting medium with DAPI (Vector 
Laboratories Inc, Burlingame, CA). Images were acquired using a Nikon Eclipse 80i 
microscope and processed using MetaMorph (Molecular Devices, Sunnyvale, CA). 
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Table 1: Quantitative PCR primer/probe sets. 
Primer and probe sequences for RNA expression are shown in a 5’ to 3’ orientation. 
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CHAPTER 3: 
Host Response to Cowpox Virus Footpad Infection 
 22 
 
 
In vivo studies of CPXV are relatively rare and have typically utilized intranasal 
inoculation (30, 39, 90). These infections model the natural route of smallpox virus 
transmission and the proposed mechanism of dissemination by bioterrorists. However, 
the natural route of transmission for CPXV is contact-mediated both within the host 
reservoir during zoonotic spread to other species including humans (6, 8, 91). We have 
therefore examined CPXV infection using a footpad injection model in order to study the 
immediate host response to infection under normal physiological conditions. Only a few 
studies have employed CPXV footpad infection and there are no data available 
documenting the host response regarding this route of infection (92, 93). Therefore, we 
first sought to characterize the immediate immune response in the down-stream popliteal 
LN.  
 
Determining Infectious Dose 
In order to choose a dose to study a sublethal inoculation and infection that occurs 
following zoonotic transmission, we performed survival studies in C57BL/6 mice using 
an intraperitoneal (IP) route of inoculation which mimics systemic infection. We chose to 
perform survival studies with this route of infection because a previously published 
reports indicate that footpad infection with CPXV does not result in lethality (92, 93). 
C57BL/6 mice were inoculated with doses of CPXV ranging from 1.567x106 pfu/mouse 
to 1.26x108 pfu/mouse and mortality and morbidity were observed. This survival curve 
experiment indicated an LD50 of 1.155x107 pfu/mouse during systemic infection. When 
mice were challenged IP with CPXV, all mice showed signs of illness including ruffled 
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fur and hunched posture. Additionally some, but not all mice developed lesions on their 
tails which resolved by 30 days post infection (dpi). Mice treated with higher doses of 
CPXV also lost of up to 10% of original weight before either succumbing to infection or 
recovering (Figure 1A). Following initial weight loss, surviving mice gained weight and, 
by 28 dpi, ranged from 100-125% of initial weight. At the lowest dose studied, 1.567x106 
pfu/mouse, all of the mice survived infection. Therefore, all subsequent experiments were 
carried out using a dose of 1.5x106 pfu/mouse. By choosing this sublethal systemic dose 
of virus, we were then able to perform our studies in hosts with ensured survival. 
 
Lymphocyte Expansion Following CPXV Infection 
The LN plays a crucial role in immunosurveillance by collecting infectious 
antigens from the periphery in an environment that increases the likelihood of interaction 
between antigen presenting cells (APCs) and circulating naïve and memory T and B cells 
(94). One of the hallmarks of infections and inflammatory reactions is lymphadenopathy. 
This is the consequence of recruitment, expansion and retention of lymphocytes in the 
draining LN while an immune response is primed resulting in characteristically swollen 
LNs. Indeed, following footpad infection with CPXV, the draining popliteal LN was 
enlarged and many lymphocyte populations were expanded.  
Innate lymphocytes including macrophages, neutrophils, and DCs, play a critical 
role in limiting viral replication and spread early following infection as well as 
simultaneously priming an appropriate adaptive immune response. These innate 
lymphocytes are characterized by their ability to phagocytose viral particles and 
recognize infection via PRRs which then stimulates an antiviral state (95, 96). Both 
macrophages and neutrophils function by producing inflammatory cytokines, 
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antimicrobial products, and reactive nitrogen and oxygen species that directly kill 
infected cells. Following CPXV infection, we have found that while macrophages were 
more quickly expanded, both macrophage and neutrophil populations were substantially 
increased by 3 dpi (Figure 2A, 2B). Pathogens are also phagocytosed and detected in the 
draining LN by resident DCs or at the site of infection, stimulating trafficking of 
migratory DCs to the draining LN (97, 98). The detection of most infections that occur in 
the periphery is mediated by a variety of migratory DC subsets, including dermal and 
Langerhan DCs. These migratory DCs are then thought to be responsible for stimulating 
the immune response in the draining LN either directly or indirectly by passing antigens 
to LN resident DCs. Surprisingly, the migratory DC population did not greatly expand at 
early time points following CPXV footpad infection in comparison to the homeostatic 
trafficking of this subset found in the non-draining LN (Figure 2C). In contrast, the LN 
resident DC population was significantly increased at 2 and 3 dpi, suggesting that this 
subset of DCs might play a more significant role following CPXV infection (Figure 2D). 
Whether LN resident DCs were expanded via in situ proliferation or recruitment and 
differentiation of blood monocytes was not determined at this time. All of these data 
demonstrated that innate immune cell populations are expanded in the draining LN 
following CPXV footpad infection. 
The LN is an important site for priming an adaptive immune response as it 
provides a location for relatively rare naïve and memory T and B cells to interact with 
antigen bearing APCs. Under homeostatic conditions, T and B cells are recruited to the 
lymph node from circulation through high endothelial venules (99). If these cells do not 
encounter APCs displaying cognate antigens, they then either migrate out through the 
efferent lymph or are returned to circulation through the thoracic duct (94). When a T or 
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B cell recognizes its cognate antigen displayed on an APC, they are arrested in the LN 
where they undergo clonal expansion and acquire effector functions including cytolytic 
ability, antibody production and directional homing to the site of infection. Following 
CPXV infection, we found an increase in the total numbers of both T and B cells in the 
draining LN suggesting that there was an increased recruitment or retention of these cells 
to select CPXV-specific T and B cells (Figure 3A, 3B). When a marker of the cell cycle 
was examined in the T and B cell populations, we found that the majority of these cells 
were not replicating (Figure 3C, 3D). Therefore, as expected, T and B cells are recruited 
to and retained in the draining LN following CPXV infection. 
Under homeostatic conditions in the mouse, NK cells are excluded from LNs as 
they do not express CCR7, which binds to CCL19 and CCL21 produced by cells in high 
endothelial venules (74). Following CPXV infection, we observed a statistically 
significant increase in the percent and total number of NK cells in the draining lymph 
node following infection beginning as early as 18 hours post infection (hpi) (Figure 4A, 
4B). This expansion occurred quite rapidly and was maintained for up to 6 dpi before the 
NK cell population began to contract. These data indicated that the NK cell population is 
specifically expanded in the draining LN, suggesting a potential role following CPXV 
infection. Aside from the migratory DC population, all lymphocyte populations examined 
expanded following CPXV footpad inoculation in the C57BL/6 system. 
 
CPXV Replication and Spread  
Zoonotic CPXV disease in immunocompetent humans is often limited to the site 
of infection, with little to no spread of lesions from the site of inoculation (9). In order to 
determine if and where CPXV was able to spread and replicate following footpad 
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inoculation in mice, we measured viral titers in a variety of organs. First, traditional 
plaque assays were performed to assess viral titers in the draining LN, spleen, and liver. 
We found that CPXV was capable of infecting and replicating in the draining LN (Figure 
5A) but that there was limited spread to the spleen where there appeared to be little to no 
replication of the virus, indicated by consistently low titers over time (Figure 5B). In 
contrast, in the liver no plaques were observed at any time, suggesting CPXV did not 
spread to this organ following footpad infection (data not shown). These data 
demonstrated that CPXV can spread from the site of inoculation and replicate to high 
titers in the draining lymph node. 
Since qPCR provides a more sensitive measurement of viral replication, we used 
this method to further characterize viral spread by quantitating viral genome copy number 
in the draining LN, lungs, spleen, liver, kidney, uterus and ovaries. Viral genome copies 
again demonstrated that CPXV could infect and replicate in both the draining LN and to a 
high degree (Figure 6B). Meanwhile, minimal copy numbers were found in the lung and 
spleen (Figure 6C, 6D) while very few to no genome copies were found in the liver, 
kidney, uterus and ovaries at 3 dpi (Figure 6E, 6F, and 6G), but viral genome copies were 
elevated in all organs except the spleen at 6 dpi. The data obtained by qPCR from the LN 
and spleen showed a similar trend to the data obtained by traditional plaque assay, 
validating this technique. We were also able to detect some viral replication in the liver at 
6 dpi, in contrast to traditional plaque assay, demonstrating the increased sensitivity of 
this system.  
 
NK Cells Prevent Viral Replication 
 27 
NK cells have been shown to be important for resistance to systemic infection 
with VV and footpad infection with ECTV (80-82). As the NK cell population was 
highly expanded in the draining lymph node following infection, we hypothesized that 
they were playing a role limiting CPXV infection. To investigate this hypothesis, we 
performed systemic antibody mediated depletion of NK cells prior to infection with 
CPXV (100). We found that following NK cell depletion (Figure 6A), viral replication in 
the draining LN was significantly increased in comparison to control antibody treated 
mice (Figure 6B). Additionally, there was a subtle trend toward increased viral spread in 
the spleen and more significantly in the lung when NK cells were not present at both 3 
and 6 dpi (Figure 6C, 6D). The depletion of NK cells did not lead to an increased 
complete systemic spread at early times following infection, as viral replication in the 
liver, kidney, uterus and ovaries (Figure 6E, 6F and 6G) did not increase at 3 dpi. Lack of 
NK cells also did not affect secondary viremia in these organs at 6 dpi, suggesting NK 
independent that CPXV spread is. In addition to increased viral replication in the draining 
LN at 3 and 6 dpi, there was also a subtle delay in the clearance of CPXV from the LN 
and foot in NK cell depleted mice in comparison to control antibody treated mice at 12 
dpi (Figure 7, 7B). Taken together, these data suggest that the expanded NK cell 
population is playing a role in limiting viral replication which prevents systemic viral 
spread. 
 
Discussion: 
Here we demonstrate that lymphocyte expansion in the draining LN in response to 
CPXV footpad infection does not appear to be impaired despite the expression of 
numerous virally encoded inhibitory proteins. Almost all populations of lymphocytes 
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examined were expanded in the draining LN except for migratory DCs.  Additionally, we 
found a substantial increase in the NK cell population whose role in CPXV infection has 
not been previously studied. CPXV replication appears to be limited to the LN at early 
time points following infection, but can later spread to other organs. Following systemic 
depletion of NK cells, we found dramatic increases of viral burden in the draining LN. 
Also, spread to some but not all organs was affected in mice lacking NK cells, implying 
that NK cells prevent dissemination to distant sites. 
Many in vivo studies of orthopoxvirus family members focus on routes of 
infection that model either systemic or aerosolized infections (30, 39, 90). Few studies 
exist that model a natural route of infection that mimics natural transmission both within 
the host reservoir and to zoonotic hosts. Rare studies have employ a footpad model of 
infection using CPXV, and these do not address the host response (10, 92, 93). Moreover, 
zoonotic infections have only been studied after development of symptoms leaving the 
immediate innate immune response to CPXV undocumented.  
 Zoonotic infections in immunocompetent humans are characterized by lesions 
that are limited to the site of inoculation, where it is thought that CPXV infects through 
abrasions in the skin. These lesions resolve in approximately two weeks. Other symptoms 
also include fever, myalgia, headache, nausea and lymphadenopathy (6, 8, 9). In the 
footpad model, mice also develop lymphadenopathy, do not develop lesions outside the 
region of inoculation and become disease free after 2-3 weeks. It appears that the footpad 
model in mice closely mimics the zoonotic infection of humans making it a relevant 
model system to study CPXV. 
A previous study using CPXV footpad inoculation was performed in outbred mice 
and reported replication limited to the footpad and a lack viral spread and replication 
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(93). Further viral or host responses were not examined. We used the C57BL/6 strain of 
mice in these studies because many genetic knockouts have been developed this 
background including many host response factors which may play a role in the response 
to CPXV infection. In contrast to the previous study, when we examined titers in 
C57BL/6 after footpad inoculation, we found extensive replication in the draining LN 
and evidence of spread to the spleen by plaque assay. This discrepancy between this and 
previous studies is most likely due to the differences between strains of mice and the 
infectious dose. We were also able to detect viral genome copies not only in the LN and 
spleen but also in the lungs, kidney, liver, uterus and ovaries using a sensitive 
quantitative PCR method.  
We next assessed the contribution of the innate immune response to 
lymphadenopathy by monitoring various lymphocyte populations in the draining LN over 
the course of infection. A detailed examination of lymphocyte populations following 
CPXV infection has, to our knowledge, not previously been undertaken. 
Lymphadenopathy resulted from an expansion of most lymphocyte populations 
examined, including both innate and adaptive lymphocyte populations. Lymphocyte 
populations appeared to expand normally following CPXV, with the potential exclusion 
of migratory DCs. An expansion of this population was never observed following CPXV 
infection in levels greater than the homeostatic migration in the non-draining LN. 
Whether the lack of migratory DC expansion is due to apoptosis at the site of infection 
following primary infection of the DCs or due to a specific inhibition of migratory DC 
recruitment to the draining LN is unknown. Following examination of the expansion of 
lymphocytes in the draining LN, we were most interested in the robust expansion of the 
relatively rare LN NK cell population. NK cells are known to be important not only for 
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lysis of infected cells, but also for priming a TH1 adaptive immune response when 
recruited to draining LNs. We thus postulated that NK cells might be important for 
resistance to CPXV infection. In addition, a role for NK cells has also, to our knowledge, 
never been studied following CPXV infection but has been demonstrated to be important 
for resistance to other orthopoxviruses such as VV and ECTV.  
CPXV has the largest genome in the orthopoxvirus genus (20) and contains 
several open reading frames not found in either VV or ECTV genomes. This includes two 
ORFs, CPXV012 and CPXV203, that potently down-regulate the expression of MHC 
class I (29-32).While this might render infected cells sensitive to NK cell-mediated lysis, 
CPXV also encodes another ORF, CPXV018, that binds in vitro with high affinity to the 
NKG2D activation receptor, blocks its recognition of ligands on target cells and prevents 
in vitro NKG2D mediated lysis (85). Additionally, all orthopoxviruses encode a number 
of cytokine binding proteins which may also limit the activation of NK cells, such as one 
specifically targeting IL-18 (34), a well known mediator of NK cell activation.  It is 
therefore possible that NK cell populations may be expanded but effectively blocked 
from functioning by the immunomodulatory ORFs expressed by CPXV. In addition to 
these known potential modulators for NK cell function, additional unknown modulators 
may exist.   
To investigate whether NK cells were playing a role in CPXV resistance, we 
performed systemic depletion of NK cells prior to footpad infection. The most striking 
increase in viral burden after depletion occurred in the draining LN, where we measured 
a two-log increase in viral replication. We also observed a more subtle increase in viral 
genome copy number in the lung and spleen at both 3 and 6 dpi, suggesting that NK cells 
prevent spread to these organs at these time points. Another subtle increase in viral 
 31 
burden at later time points following infection was observed in the draining LN and in the 
foot, indicating that NK cells also play a role in viral clearance. Whether this was due to 
limiting initial viral burden shortly after infection or due to priming of the adaptive 
immune response is still unknown. This pattern of increased viral burden suggested to us 
that NK cells were playing an important role in the draining LN where viral replication 
was limited thus preventing viral spread. 
It is important to note that when C57BL/6 mice were inoculated in the footpad, no 
mice succumbed to infection. This is in contrast to the increased mortality of mice 
following systemic depletion or genetic absence of NK cells during infection with either 
ECTV or VV (80-82). It is possible that NK cell depleted mice would succumb to 
infection following a larger dose of CPXV, but increased mortality was observed even 
with sub-lethal doses of ECTV and VV. Thus, while NK cells play an important role in 
resistance to CPXV, similar to ECTV and VV, they are not absolutely required for 
survival. 
Also, despite viral dissemination at later time points after CPXV footpad 
infection, no lesions have been observed outside the site of inoculation. These data 
suggest that the primary site of early CPXV infection and replication is the foot and 
draining LN, from where it may rarely escape into the blood and be spread to the spleen 
and/or lungs. If CPXV replicates to sufficient titers in the draining LN and footpad, a 
secondary viremia may occur in other organs at later time points. In addition, this route of 
infection seems to mimic zoonotic infection where there is primary replication at the site 
of inoculation and systemic disease is not observed. This makes the footpad route of 
infection a relevant model to study both spread within the host reservoir, but also 
zoonotic spread in humans. 
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Figure 1: Morbidity and mortality following CPXV footpad infection. 
Age and sex matched C57BL/6 mice were inoculated in the footpad with indicated doses 
of CPXV in 25µL volume. Mice were weighed every day for the first 11 days, then every 
other day for the next week and before sacrifice at the conclusion of the experiment. (A) 
Weight change and (B) mortality over time following CPXV infection are depicted. 
N=10 mice for 1.26x108 pfu/mouse and 6.3x107 pfu/mouse, n=8 mice for 1.4x107 
pfu/mouse, n=7 mice for 4.7x106 pfu/mouse and n=6 mice for 1.567x106 pfu/mouse. 
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Figure 2: Kinetics of innate lymphocyte expansion following CPXV footpad 
infection. 
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106 
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs 
were isolated, stained and analyzed by flow cytometry. Following exclusion of dead 
cells, total (A) macrophages (F4/80+CD11b+), (B) neutrophils (Ly6G+SSC+), (C) 
migratory DCs (CD11c+MHCIIhigh) and (D) LN resident DCs (CD11c+MHCII+) were 
identified. Cell numbers were ascertained using trypan blue exclusion, then multiplied by 
the percentage of population found by FACS analysis.  A graph depicting the average of 
3 independent experiments is shown. 
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Figure 3: Kinetics of adaptive lymphocyte expansion following CPXV footpad 
infection. 
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106 
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs 
were isolated, stained and analyzed by flow cytometry. Total (A) T cells (CD3+CD19-
NK1.1-) and (B) B cells (CD19+CD3-NK1.1-) were identified. Cell numbers were 
ascertained using trypan blue exclusion, then multiplied by the percentage of population 
found by FACS analysis. A graph depicting the average of 5 independent experiments is 
shown. Following extracellular staining, lymphocytes were fixed, permeablized and 
stained for Ki67. Total (C) T cells (CD3+CD19-NK1.1-Ki67+) and (D) B cells 
(CD19+CD3-NK1.1- Ki67+) were identified. A graph depicting the average of 3 
independent experiments is shown. 
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Figure 4: Kinetics of NK cell expansion following CPXV footpad infection. 
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106 
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs 
were isolated, stained and analyzed by flow cytometry. (A) Percent and (B) total NK cells 
(NK1.1+CD3-CD19-) were identified. Cell numbers were ascertained using trypan blue 
exclusion, then multiplied by the percentage of population found by FACS analysis. The 
graphs depict average of n=6 independent experiments (18 hpi), n=14 independent 
experiments (1 dpi), n=3 independent experiments (36hpi), n=8 independent experiments 
(2 & 3 dpi), and n=2 independent experiments (6 & 9dpi). Paired Student’s t-test: (*) = p 
< 0.05; (**) = p < 0.005; (***) = p < 0.0005. 
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Figure 5: CPXV titers following footpad inoculation. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu of CPXV in the 
footpad and at indicated times, organs were removed and viral titers were assessed in the 
draining LN (A) and spleen (B) by plaque assay. Dotted lines indicate the limit of 
detection by the assay. Symbols indicate individual mice and the mean and SEM are 
depicted. N=4 to 5 mice/group were analyzed for each time point. 
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Figure 6: Systemic NK cell depletion leads to increased viral burden in some but not 
all organs following early footpad inoculation. 
Age and sex matched C57BL/6 mice were treated IP with 200µg control (mAR) or NK 
cell-depleting (anti-NK1.1, PK136) antibody 2 days prior to infection and 4 dpi. (A) NK 
cell depletion was assessed in the non-draining LN by staining lymphocytes and 
identifying NK cells (NK1.1+NKp46+CD3-CD19-) cells. Cell numbers were ascertained 
using trypan blue exclusion, then multiplied by the percentage of population found by 
FACS analysis. At indicated time points, organs were removed and viral titers were 
assessed by quantitative PCR in the (B) LN, (C) lungs, (D) spleens, (E) livers, (F) 
kidneys and (G) uterus and ovaries. CPXV copy number was normalized to $-actin copy 
numbers and then multiplying by 1000. Symbols indicate individual mice and lines 
indicate the mean. N=4 to 5 mice/group were analyzed for each time point. Data are 
representative of 2-3 independent experiments. 
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Figure 7: CPXV persists longer in mice that were systemically depleted of NK cells. 
Age and sex matched C57BL/6 mice were injected IP with 200µg/mouse of control 
(mAR) or NK cell depleting (anti-NK1.1, PK136) antibody 2 days prior to infection, 4 
and 10 dpi. At indicated time points, (A) LNs and (B) feet were isolated. DNA was 
generated and CPXV copy number was normalized to $-actin copy numbers and then 
multiplied by 1000. Symbols indicate individual mice and lines indicate the mean. N=4 to 
5 mice/group were analyzed for each time point. 
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CHAPTER 4: 
The Mechanism of NK Cell Recruitment 
 47 
Following CPXV footpad infection we saw a dramatic and rapid expansion of NK cells in 
the draining LN. Murine NK cells are known to lack expression of CCR7, the 
homeostatic chemokine receptor responsible for T and B cell trafficking into secondary 
lymphoid organs in response to its ligands CCL19 and CCL21 (74). It is this lack of 
CCR7 expression that is thought to lead to the exclusion of murine NK cells from the LN. 
Therefore, it was of interest to determine the mechanism of NK cell population expansion 
following CPXV infection. 
 
The Expansion of the NK Cell Population is Not Due to Proliferation 
The rapid expansion of the NK cell population in the draining LN following 
CPXV could be the result of either in situ proliferation or the recruitment of NK cells 
from other areas. To determine if NK cells were undergoing proliferation, we isolated 
NK cells from the draining LN and co-stained them for Ki67, a cell cycle marker. While 
some NK cells isolated from the draining LN did stain positively for Ki67, the majority 
of NK cells did not express Ki67 (Figure 8). These data indicate that NK cell population 
expansion is mediated by active recruitment of NK cells to the draining LN following 
CPXV infection. 
 
NK Cell Subset Surface Staining Profiles 
There are several subsets of NK cells residing in different organs that have been 
characterized (101-103). Research has predominantly been performed with NK cells 
isolated from the spleen as it contains a large population of NK cells that is easy to 
isolate. Several groups, including our lab, have also characterized a rare alternatively 
matured subset of thymic NK cells. To determine if the expanded NK cell population 
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resulting from CPXV infection resembled either of these subsets, we analyzed NK cells 
isolated from the draining LN, non-draining LN, spleen and thymus for markers that can 
differentiate these populations. 
Splenic NK cells have high expression of Mac-1 (CD11b), Ly49 family receptors, 
L-selectin (CD62L), DX5 (CD49b), CD94, and NKG2D (CX5) (102). NK cells isolated 
from the draining lymph node expressed identical surface levels of splenic markers as 
NK cells isolated from the spleen (Figure 9A-F). In contrast, NK cells isolated from the 
thymus expressed lower levels of splenic markers. Thymic NK cells have been shown to 
highly express the IL-7 receptor " (IL7R", CD127) and "E integrin (CD103) (102). 
When NK cells from the draining LN were examined, they did not express thymic 
surface markers (Figure 10A, 10B). Again, NK cells isolated from the spleen and the 
draining LN had identical expression profiles for these thymic surface markers. 
Additionally, when we examined the expression of splenic and thymic markers on NK 
cells isolated from the non-draining LN, we found intermediate expression of Mac-1, L-
selectin and IL-7R". Taken together, these data show that NK cells expressing splenic 
markers are recruited to the draining LN. 
 
NK Cell Expansion is Pertussis Toxin Sensitive 
Given the rapid kinetics of the NK cell population increase, the minimal number 
of replicating NK cells, and the splenic surface marker profile of the NK cells isolated 
from the draining LN, we hypothesized that NK cells were being recruited to the draining 
LN. We isolated splenocytes from congenic mice and pre-treated them in vitro for 2 
hours with either PBS or pertussis toxin. Following pre-treatment, the cells were washed 
extensively, labeled with CFSE and mixed together before adoptive transfer into 
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congenic C57BL/6 mice. We found that donor splenic NK cells treated with PBS 
specifically increased in the draining LN following adoptive transfer and CPXV infection 
(Figure 11A, 11B). The increase in the transferred PBS-treated NK cells was similar to 
the kinetics of host NK cell increase following CPXV infection, supporting the 
hypothesis that splenic NK cells are being recruited to the draining LN following CPXV 
infection.  
These findings led us to consider chemokine receptor-dependent NK cell 
recruitment into the draining LN. As with other GPCRs, chemokine receptors signal via 
G proteins and these signals are blocked by pertussis toxin (70, 71). We thus used 
pertussis toxin to test whether chemokine receptors were important for the NK cell 
increase in the draining LN. Pertussis toxin pre-treated splenic NK cells were never found 
in the draining LN at any time point following CPXV infection (Figure 11B). Although it 
is difficult to fully control for off-target effects of petussis toxin treatment, these data 
further substantiate the possibility that splenic NK cells are being recruited to the 
draining LN following CPXV infection and additionally suggest that NK cell recruitment 
occurs via chemokine receptors. 
 
CPXV Infection Specifically Up-regulates Inflammatory Chemokines in the 
Draining LN  
As the data suggested a role for chemokines and chemokine receptor-mediated 
recruitment of NK cells following CPXV infection, we next determined specifically 
which of these were required. To examine chemokine expression in the draining LN, we 
assessed transcript levels over time following CPXV infection by use of a comprehensive 
bead-based array. In both draining and non-draining LNs over time, we examined 33 
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transcripts simultaneously: Ccl1, Ccl2, Ccl3, Ccl4, Ccl5, Ccl6, Ccl7, Ccl8, Ccl9, Ccl11, 
Ccl12, Ccl17, Ccl19, Ccl20, Ccl21, Ccl22, Ccl24, Ccl25, Ccl27, Ccl28, Cxcl1, Cxcl2, 
Cxcl3, Cxcl5, Cxcl9, Cxcl10, Cxcl11, Cxcl12, Cxcl13, Cxcl14, Cxcl15, Cxcl16 and Xcl1.  
Our analysis of these data was then informed by gene expression microarray data 
from a previously published study (59) and confirmed by our laboratory, indicating that 
NK cells express transcripts for Ccr2, Ccr5, Cx3cr1, Cxcr3, Cxcr4 and Cxcr6. We found 
that transcripts of ligands for CCR2 and CCR5, including Ccl2, 3, and 7, were up-
regulated approximately 3- to 9-fold relative to the non-draining LN transcripts (Figure 
12). Additionally, the ligands for CXCR3, namely IFN-! inducible transcripts Cxcl9, 10 
and 11, were up-regulated from 5 to 19-fold relative to transcript levels in the non-
draining LN. While transcripts for Cxcl11 were the most highly induced, CXCL11 
protein is not expressed in C57BL/6 mice due to a point mutation (104). Finally, we did 
not find an increase in ligands for CXCR4 and CXCR6 (CXCL12 and CXCL16, 
respectively). Nonetheless, CPXV infection induces up-regulation of chemokine ligands 
for chemokine receptors expressed on NK cells.  
 
CXCR3 but not CCR2 or CCR5 Is Required for Full NK Cell Recruitment 
Our analysis of chemokine up-regulation following CPXV infection and NK cell 
expression of specific chemokine receptors suggested selective involvement of CCR2, 
CCR5 or CXCR3 in the recruitment of NK cells. To further analyze these possibilities, 
we examined NK cell recruitment in chemokine receptor-deficient mice. Despite up-
regulation of transcripts for Ccl2, Ccl3 and Ccl7, there were little to no defects in 
recruitment of NK cells in mice lacking either CCR2 or CCR5 (Figure 13A, 13B). Thus, 
 51 
CCR2 and CCR5 individually do not contribute to NK cell recruitment following CPXV 
footpad infection.   
We next studied NK cell trafficking to the draining LN in CXCR3-deficient mice. 
In these mice, we found that there was a substantial defect at 3 dpi, resulting in a marked 
decrease in trafficking of NK cells following CPXV infection, although NK cell 
recruitment at earlier times was relatively unaffected (Figure 13C). In order to determine 
whether these CXCR3-dependent trafficking defects were NK cell intrinsic or extrinsic, 
we adoptively transferred a mixture of enriched splenic NK cells from wild-type and 
CXCR3-deficient mice into congenic C57BL/6 mice (Figure 13D). We found that the 
fold change of recruited donor-derived NK cells for the adoptively transferred CXCR3-
deficient NK cells was lower than for the adoptively transferred wild-type NK cells, 
especially at later time points as observed directly in the CXCR3-deficient mice (Figure 
14C). These results indicate that NK cells intrinsically require CXCR3 expression for 
maximal recruitment.  
 
Discussion 
Two mechanisms could explain NK cell expansion in the draining LN following 
CPXV infection: either in situ proliferation of rare murine LN NK cells or recruitment 
from the blood and other organs. A specific cell cycle marker indicated that while some 
NK cells in the draining LN were proliferating, the majority of the expanding NK cell 
population were not. In support of these data, NK cells in the draining LN expressed 
splenic markers and recruitment of transferred splenic NK cells was pertussis toxin 
sensitive. Comprehensive analysis of chemokine receptor expression on NK cells in 
combination with chemokine expression following infection in the draining LN focused 
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our studies on CCR2, CCR5 and CXCR3. Although transcripts for ligands of these 
receptors were up-regulated, only CXCR3 was required on the NK cell for full 
recruitment following CPXV infection. 
Productive interactions between NK cells and their targets require recruitment of 
NK cells to the relevant site. In non-infectious settings, several studies have implicated 
the requirement for CXCR3-mediated NK cell trafficking including following corneal 
epithelial injury (105), implantation of tumor cells that endogenously express IFN-! 
(106), and LPS-matured dendritic cell footpad injection (107). In contrast, during 
parasitic and viral infections, NK cells have differential requirements for chemokine 
receptors, generally not including CXCR3. Following intratracheal inoculation of 
neutropenic mice with Aspergillus fumigatus, CCR2 is required (75) whereas CCR5 is 
required in Toxoplasma gondii (76) or Herpes Simplex Virus 2 (HSV2) (108) infections, 
with higher pathogen burden in CCR5-deficient mice. However, Aspergillus and HSV2 
are not natural pathogens of rodents. For protection against MCMV, a natural pathogen 
of mice, recruitment of NK cells to the liver is mediated through CCR2 (68, 77). CXCR3 
and CCR5 are also important for NK cell trafficking from the red pulp to the T cell zone 
in the spleen following injection of polyI:C and MCMV infection (109). Finally, CXCR6 
is required for memory NK cells in the liver that respond to contact-mediated 
hypersensitivity or virus-like particles (79). Thus, several chemokine receptors are 
involved in recruitment of NK cells though little is known about NK cell recruitment to 
the draining LN in the context of natural rodent pathogens.  
In contrast to other studies using other pathogens and NK cell recruitment to other 
organs (68, 75-77, 108), we found no role for CCR2 or CCR5 individually in recruitment 
of NK cells to the draining LN following CPXV inoculation. However, it is still possible 
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that they function redundantly in the individually deficient mice as CCR2 and CCR5 
share several of the same ligands (70). To formally determine if CCR2 and CCR5 are 
required, a mouse lacking both CCR2 and CCR5 must be generated and tested. This 
would likely require the production of a single targeting construct containing deletions of 
both CCR2 and CCR5 since their genes are located within about 15 kb of each other 
(genome.ucsc.edu), making it unlikely that a double knockout can be readily generated 
by mating the CCR2- and CCR5-deficient mice. Additionally, since we analyzed 
chemokine transcript levels, not protein levels, is possible that actual chemokine proteins 
were not up-regulated following infection. Further complicating interpretation 
experiments in chemokine receptor deficient mice, CPXV encodes numerous chemokine 
binding proteins which may interfere with CCR2 or CCR5 function. 
On the other hand, we found that CXCR3 was intrinsically required for full 
recruitment following CPXV infection. Expression of CXCR3 on NK cells has been 
shown to be important for the recruitment of NK cells to tumor sites (106) and to the 
draining LN following deliberate LPS-matured dendritic cell footpad injection (107). 
CXCR3 also plays a role in re-localization of NK cells from the red pulp to the T cell 
zone of the spleen during MCMV infection (109), another rodent specific virus. 
Therefore our data is in agreement with previously published data demonstrating the 
importance of CXCR3 in the recruitment of NK cells in the context of infection with 
natural rodent pathogens. These data suggest that CXCR3 mediates NK cell trafficking 
under both non-infectious and infectious inflammatory conditions. 
Defective NK cell recruitment in CXCR3-deficient mice is most evident at 3 dpi 
when the largest increase in NK cells normally occurs. Earlier time points are less 
affected, suggesting that there is at least one other mechanism for NK cell recruitment 
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that is independent of CXCR3. There are several hypotheses that might explain this 
CXCR3-independent NK cell recruitment. One possibility is that CX3CL1, the ligand for 
CX3CR1, plays a role in NK cell recruitment. However, expression of CX3CL1 was not 
examined in the transcriptional chemokine expression array so the need for this receptor 
remains unknown. If expression of CX3CL1 was found in the draining LN relative to the 
non-draining LN, mice deficient for CX3CR1 are available and NK cell recruitment 
could easily be studied in them. Another possible mediator of recruitment may be up-
regulation of another chemokine receptor on NK cells during active infection. We did not 
evaluate this possibility because of the low numbers of NK cells in the draining LN and 
the procedural concerns regarding FACS sorting of CPXV-infected samples. Taken 
together, these data suggest that in addition to CXCR3, at least one other chemokine and 
chemokine receptor pair may function to recruit NK cells to the draining LN. 
Alternately, it is also possible that NK cells are being recruited in a non-
chemokine receptor dependent manner. Other chemotactic compounds that are induced 
by inflammation also cause NK cells to traffic including lysophosphatidic acid (LPA), 
complement component C5a, N-formyl-methionyl-leucyl-phenylalanine and leukotrienes 
(74). LPA is involved in a variety of signaling pathways and interacts with GPCRs, 
conferring pertussis toxin sensitivity, but its role following any pathogenic infection has 
not been shown (110). In contrast, poxviruses are known to encode a number of 
complement control proteins that have been extensively studied using ECTV or VV but 
not CPXV (23, 24, 111). Meanwhile, the importance of leukotrienes for NK cell 
recruitment could be quite complicated. Orthopoxviruses, including CPXV, have an 
obligate requirement for arachidonic acid metabolites for replication both in vitro and in 
vivo (112, 113). However, arachodonic acid can be used as a precursor for pro-
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inflammatory signaling molecules, including leukotrienes. To control the inflammatory 
response, CPXV encodes p38, which inhibits the synthesis of a specific intermediate that 
can be used in pro-inflammatory mediator synthesis. It is therefore possible that these 
alternate mediators of recruitment could also play a role in NK cell recruitment following 
CPXV infection. 
NK cells also express sphingosine-1-phosophate 5, another GPCR, which senses a 
high concentration of sphingosine-1-phosphate in the blood. In mice deficient in S1P5, it 
has been demonstrated that there is a decrease in the number of NK cells in the blood, 
lungs and spleen and increase in the LN and bone marrow, suggesting that it plays a role 
in NK cell egress (114). Following infection, it is possible that S1P5 becomes depressed 
in the blood to allow for lymphocyte retention, including NK cells, in secondary 
lymphoid organs to prime an immune response. Thus it is possible that CXCR3-
independent NK cell recruitment does not require another chemokine receptor, but does 
require another GPCR or pro-inflammatory mediator. 
Here we demonstrate that NK cell expansion was not due to active replication of 
rare LN NK cells but was due to recruitment of splenic NK cells. This recruitment was 
chemokine receptor-dependent and we identified the NK cell intrinsic requirement for 
CXCR3. Deficiency of CXCR3 alone, however, does not abrogate the recruitment 
phenotype, suggesting requirement of additional chemokine receptors or other 
inflammatory mediators. 
 
 
 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Expansion of the NK cell population cannot fully be explained by in situ 
proliferation. 
Age and sex matched C57BL/6 mice were infected as before and at indicated time points, 
cells from the draining and non-draining LN were isolated and stained. Following 
extracellular staining, cells were fixed, permeablized and intracellularly stained for Ki67. 
Total Ki67 expressing NK cells were identified by gating on NK cells (NK1.1+CD3-
CD19-) then looking for those that expressed Ki67. Cell numbers were ascertained using 
trypan blue exclusion, then multiplied by the percentage of population found by FACS 
analysis. The graph depicts the average of 3 independent experiments. 
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Figure 9: NK cells isolated from the draining LN following CPXV infection 
phenocopy surface staining of splenically derived NK cells. 
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the 
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained. 
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) Mac-1 
(CD11b), (B) pan-Ly49 family receptors (Ly49ADCIFH), (C) L-selectin (CD62L), (D) 
DX5 (CX5), (E) CD94 and (F) NKG2D was determined. A representative result of 2 
independent experiments is shown. Surface staining remained the same when observing 
NK cells isolated from these organs at 2 and 3 dpi. 
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Figure 10: Draining LN NK cells do not express markers of thymic NK cells. 
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the 
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained. 
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) IL-7R" 
(CD127) and (B) integrin "E (CD103) was determined. Representative results of 2 
independent experiments are shown. Surface staining remained the same when observing 
NK cells isolated from these organs at 2 and 3 dpi. 
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Figure 11: NK expansion in the draining LN is pertussis toxin sensitive following 
CPXV infection. 
Splenocytes isolated from congenic C57BL/6 (CD45.2) and B6.LY5.2 (CD45.1) mice 
were pre-treated in vivo with PBS or pertussis toxin for 2 hours at 37°C, 5% CO2 before 
being washed, CFSE labeled, mixed and co-injected IV into C57BL/6 mice. Immediately 
following adoptive transfer, the mice were infected with 1.5x106 pfu of CPXV in the 
footpad. At the indicated time points, LNs were harvested and NK cells (NK1.1+CD3-
CD19-) were identified. Host NK cell recruitment (CFSE-) (A) or donor NK cell 
recruitment (CFSE+) (B) is shown over time. Data are representative of 2 independent 
experiments. 
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Figure 12: Inflammatory chemokine transcripts are up-regulated following CPXV 
infection. 
RNA transcript levels were assessed in age and sex matched C57BL/6 mice infected with 
1.5x106 pfu of CPXV in the footpad at indicated time points by multiplex gene 
expression analysis. LNs from 3 independently infected mice were isolated and lysates 
from either the non-draining or draining LN were generated, run in triplicate, and 
chemokine transcripts normalized to the control Hprt1 transcript for each sample. The 
fold change indicated in each square depicts the average transcript level in the draining 
LN relative to the non-draining LN. 
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Figure 13: NK cell recruitment occurs in the absence of CCR2 and CCR5 but 
intrinsically requires CXCR3 expression following CPXV infection. 
Age and sex matched C57BL/6 and (A) CCR2-deficient, (B) CCR5-deficient or (C) 
CXCR3-deficient mice were infected with 1.5x106 pfu of CPXV. At indicated time 
points, lymphocytes from the non-draining and draining LNs were isolated, stained and 
analyzed by flow cytometry. Total NK cells (NK1.1+CD3-CD19-) were identified. The 
graphs are the average of 3 independent experiments. (D) B5.LY5.2 (CD45.1) and 
CXCR3-/- (CD45.2) splenocytes were isolated and enriched by negative selection before 
being CFSE labeled, mixed and co-transferred IV into C57BL/6 mice. One day after 
transfer, mice were infected as before and NK cell populations were examined at 
indicated time points. To analyze the recruitment in this system, the total number of 
recruited wild-type or chemokine deficient NK cells at 2 and 3 dpi were compared 
relative to the initial time point at 1 dpi. A representative result of 3 independent 
experiments is shown. 
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CHAPTER 5: 
Up-stream Requirements for NK Cell Recruitment and Viral Burden 
 69 
 NK cell recruitment to the draining LN is mediated through chemokine induction 
in the draining LN and at least one chemokine receptor on the NK cell. The induction of 
inflammatory chemokines indicated that there is viral recognition in the draining LN. 
This chapter explores the upstream requirements for NK cell recruitment, including the 
cells required and the signaling pathway leading to inflammatory chemokine induction. 
 
IFN-! is Required for NK Cell Recruitment 
As discussed previously, ligands for CXCR3, including CXCL9 and CXCL10, are 
induced by IFN-!. In order to further investigate the role that IFN-! was playing upstream 
of NK cell recruitment, we examined mice that were deficient for IFN-! receptor 1 
(IFN!R1). These mice still produce IFN-! but are unable to respond to its stimulus. 
Following CPXV infection, we observed a lack of recruitment of NK cells at both 2 and 3 
dpi (Figure 14A). In fact, at these time points, levels of NK cell recruitment were lower 
in IFN!R1-deficient mice than in CXCR3-deficient mice, suggesting that other factors 
important for NK cell recruitment are also induced by IFN-!. 
Another method we employed to demonstrate the importance of IFN-! was to 
observe NK cell recruitment in C57BL/6 mice given an injection of control or IFN-! 
neutralizing antibody two days prior to infection. The lack of NK cell recruitment at 3 dpi 
in mice treated with neutralizing antibody recapitulated the results seen in IFN!R1-
deficient mice (Figure 14B). In mice that received control antibody, the NK cell 
recruitment observed was similar to NK cell recruitment in CPXV infected 
unmanipulated mice. Interestingly, there did not appear to be a defect at 2 dpi. This could 
be explained by incomplete inhibition of IFN- ! signaling by neutralizing antibody or 
insufficient localization to the draining LN until later time points.  
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Supporting our hypothesis that IFN-! is upstream of CXCR3 signaling required 
for NK cell recruitment, Cxcl9 and Cxcl10 transcripts were not induced in mice that were 
pre-treated with IFN-! neutralizing antibody (Figure 14C, 14D).  Meanwhile, CPXV 
infection in control antibody treated mice induced high levels of Cxcl9 and Cxcl10 
transcripts at 3 dpi. The inhibition of Cxcl9 and Cxcl10 transcript induction was selective, 
as expression of control transcripts for homeostatic trafficking chemokines Ccl19 and 
Ccl21 showed little to no difference between control and IFN-! neutralizing antibody 
treatment (Figure 14E, 14F). Taken together, these data indicated that IFN-! is crucial for 
the selective induction of chemokines responsible for NK cell recruitment following 
CPXV infection. 
 
CCR7 is Extrinsically Required for NK Cell Recruitment 
Murine NK cells do not express transcripts or protein for CCR7, which leads to 
their exclusion from secondary lymphoid organs in mice (74). When analyzing the 
microarray data, we also confirmed a lack of Ccr7 transcript expression in both resting 
and cytokine activated NK cells. Expression data published online also demonstrate low 
levels of Ccr7 in NK cells relative to other lymphocytes such as T cells (immgen.com). 
During our analysis of the individual chemokine receptor deficient mice, as a control we 
also examined mice deficient for CCR7. Surprisingly, given the absence of expression of 
Ccr7 transcripts in NK cells, mice lacking CCR7 had a complete reduction of NK cell 
recruitment at all time points observed following CPXV infection (Figure 15A).  
The classical paradigm of pathogen sensing for peripheral DCs involves up-
regulation CCR7 expression during the maturation process (115, 116). This up-regulation 
stimulates migration of DCs from the periphery to the draining LN where they directly 
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prime the immune response or pass antigens to other LN resident cells that prime the 
immune response (107). It is also well documented that after localization to the draining 
LN, DCs interact with NK cells inducing a positive feedback loop, where DCs produce 
IL-12, stimulating NK cells to produce IFN-! and subsequently causing further 
maturation of the DCs and IL-12 production (44, 45, 53, 117).  
It seemed a likely hypothesis that CCR7 was required for DC trafficking from the 
foot to the LN, where they stimulated the recruitment of NK cells as a consequence of 
this positive feedback loop. To verify the NK cell intrinsic or extrinsic requirement of 
CCR7, we isolated and enriched NK cells from wild-type or CCR7-deficient congenic 
mice, labeled the cells with CFSE and co-transferred them into congenic wild-type mice 
prior to CPXV infection. We found that the transferred NK cells deficient in CCR7 
trafficked with similar kinetics to co-transferred wild-type NK cells (Figure 15B). These 
data indicated that the requirement for CCR7 was NK cell extrinsic as hypothesized. 
 
Abolished Trafficking of NK Cells in Diphtheria Toxin Treated CD11c-DTR Mice 
 To test the potential requirement for DCs to induce recruitment of NK cells 
following CPXV infection, we employed CD11c-DTR transgenic mice. These transgenic 
mice encode the high affinity human diphtheria toxin receptor under control of the 
CD11c promoter (118, 119). This system allows for selective depletion of cells 
expressing CD11c when treated with diphtheria toxin. Given dosage variations found in 
the literature and NK cell expression of CD11c, we first performed a dose-response 
experiment with diphtheria toxin to determine the ideal concentration. Previously 
published studies that used models of peripheral depletion administered as much as 
20ng/g body weight of diphtheria toxin, but when we tested that dose, we found that NK 
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cells and macrophage total cell numbers were also reduced (Figure 16A-D). Using a 
lower dose of 5 ng/g body weight of diphtheria toxin, there appeared to be little reduction 
of these cell types, but conventional DCs (CD11c+MHCII+) were still depleted (Figure 
16E, 16F). 
 C57BL/6 or CD11c-DTR transgenic mice were treated with diphtheria toxin prior 
to inoculation with CPXV. Following verification that the CD11c expressing DCs were 
ablated in the diphtheria toxin treated transgenic mice but not in C57BL/6 mice, we next 
examined the NK cell population. NK cell recruitment was not affected in control mice 
treated with diphtheria toxin. In contrast, in the treated transgenic mice, we found that, 
similar to the CCR7-deficient mice, recruitment of NK cells did not occur in response to 
CPXV infection at either time point observed (Figure 16G). Taken together, these data 
suggested that a CD11c- and CCR7-expressing cell, potentially a migratory DC, was 
important for mediating NK cell recruitment following CPXV infection. 
 
DCs Are Not Sufficient to Restore NK Cell Trafficking 
Since depletion experiments indicated that DCs were involved upstream of NK 
cell recruitment following CPXV infection, we next addressed if DCs were sufficient to 
recruit NK cells. For these studies, we employed in vitro Flt3-matured BMDCs, which 
have a less mature and inflammatory phenotype (97, 120). We also wanted to spatially 
separate the injection sites of transferred BMDCs and virus since in vitro experiments 
have shown that infection of BMDCs prevents up-regulation of maturation markers and 
results in non-productive infection (47, 48, 121). Using the CCR7-deficient mice, we 
injected BMDCs on the top of foot opposite from where we normally inject the virus. 
Following transfer of BMDCs, we observed trafficking of transferred cells to the draining 
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LN as has been previously reported (Figure 17A) (116). However, when BMDCs were 
injected in the same foot as the virus, trafficking of BMDCs to the draining LN was 
highly diminished. It is possible that the amount of virus injected is so overwhelming that 
even a physical barrier does not prevent infection of the majority of the injected BMDCs 
leading to either a lack of maturation and subsequent up-regulation of CCR7 required for 
migration or apoptosis.  
 Additionally, in these experiments we began to encounter abnormalities in the 
CCR7-deficient mice, such as inconsistent and expanded NK cell populations in the 
draining LN following CPXV infection (Figure 17B). Further investigation of the 
literature revealed that CCR7-deficient mice develop several types of spontaneous 
autoimmune diseases, often resulting in lymphadenopathy (122, 123). Indeed, 
examination of CCR7-deficient mice in our colony showed that there was a broad range 
in the total number of cells in the draining LN, from 60,000 to 1,000,000 cells in 
unmanipulated mice regardless of the age of the mouse (Figure 17C). In comparison, 
total cells isolated from wild type mice were tightly grouped and fell around 500,000 
cells per LN. This wide variation in total cell number in unmanipulated CCR7-deficient 
mice makes it impossible to study NK cell recruitment in these mice. 
 Next, we attempted to complement NK cell recruitment in CD11c-DTR 
transgenic mice that had been depleted of DCs prior to transfer of in vitro Flt3L-matured 
BMDCs and inoculation with CPXV. When examining lymphocytes isolated from the 
draining and non-draining LN, it was hard to detect transferred BMDCs in the CD11c-
DTR mice because LNs were markedly smaller (Figure 18A, 18B). Additionally, even 
with very minimal numbers of BMDCs in the draining LN of mice deficient for DCs, NK 
cells were not observed to be recruited to the draining LN following BMDC 
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complementation (Figure 18C). Again, in control C57BL/6 mice, following footpad 
injection of only BMDCs, there was trafficking of the transferred cells from the foot to 
the draining LN which was diminished when CPXV was concurrently injected. These 
results suggested that while DCs may be involved in NK cell recruitment following 
CPXV infection, the minimal number that trafficked to the draining LN was not sufficient 
for recruitment of NK cells and that another cell might also be required. 
 
Dermal DCs Do Not Appear to Play a Role in NK Cell Recruitment 
In vitro infection of BMDCs with orthopoxviruses prevents maturation of 
BMDCs, demonstrated by the lack of up-regulation of MHC class II and co-stimulatory 
molecules (47, 48, 121). As previously discussed, CPXV is known to express two ORFs 
that potently down regulate expression of MHC class I on infected cells (29-32). 
However, our lab has also demonstrated that CD8+ T cells are required for resistance to 
CPXV infection, as systemic depletion of CD8+ T cells leads to decreased survival 
following infection with a mutant CPXV that cannot down-regulate MHC class I (30). If 
directly infected DCs cannot prime a CD8+ T cell response, then it is likely that the CD8+ 
T cell response is primed through cross presentation by a dermal DC subset that 
expresses CD103 (97, 124, 125). Additionally, previous investigations examining 
migratory DC trafficking from the periphery to the draining LN demonstrated that dermal 
DCs arrived earlier than langerin-expressing DCs in the draining LN (126-128). This 
earlier recruitment makes them likely candidate DC subset to stimulate early NK cell 
recruitment. Given the importance of cross-presenting DCs for viral resistance, we 
hypothesized that this dermal CD103 expressing DC subset was also responsible for NK 
cell recruitment.  
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We examined the role for cross presenting DCs by using BATF3-deficient mice, 
which have been shown to selectively lack the CD103+ DC population (88). When we 
infected the BATF3-deficient mice with CPXV, we found that there was little to no 
difference in NK cell recruitment between the wild-type and BATF3-deficient mice at 
time points observed (Figure 19A, 19B). These results suggested that cross-presenting 
DCs were not essential for NK cell recruitment. Since we also did not observe increased 
migratory DC recruitment to the draining LN and were unable to complement NK cell 
recruitment with in vitro matured DCs, we hypothesized that another cell type was 
important for stimulating NK cell recruitment in response to CPXV infection. However, 
we remain unable to fully discount a possible contribution by a DC subset for NK cell 
recruitment following CPXV infection. 
 
Macrophage Depletion Leads to Deficiency in NK Cell Recruitment 
 Macrophages have been shown to line the SCS of the LN, where they 
phagocytose and detect free viral particles that arrive from the periphery through the 
lymphatics (94, 129, 130). Additionally, previous data from our lab using an IP 
inoculation of CPXV that expresses GFP in the place of CPXV203 has demonstrate a 
preferential infection of CD169+ macrophages in the draining mediastinal LN (78). In 
agreement with these findings, several other labs have recently shown CD169+ 
macrophage co-localization with a number of pathogenic infections, including MVA and 
VV, in the draining LN following cutaneous inoculation (131, 132). Finally, it has also 
previously been demonstrated that the SCS macrophage population is sensitive to 
diphtheria toxin depletion in the CD11c-DTR transgenic mice (133). In light of DCs 
being necessary but not sufficient for the trafficking of NK cells to the draining LN 
 76 
following infection, we decided to examine the role that macrophages play in NK cell 
recruitment.  
 To specifically deplete macrophages in the draining LN, five days prior to CPXV 
infection we subcutaneously injected liposomes encapsulating clodronate. When 
examined by immunohistochemistry and, as previously described, in mice were that 
treated with clodronate-loaded liposomes the SCS macrophage population that express 
CD169 was depleted in the LN (Figure 20A). Mice that received liposomes encapsulating 
PBS had an intact macrophage population and recruited NK cells when examined by flow 
cytometry 3 dpi (Figure 20B, 20C). In contrast, mice that were injected with clodronate-
loaded liposomes had minimal numbers of classical macrophages when examined by 
flow cytometry and were not able to recruit NK cells. In fact, following macrophage 
depletion and subsequent CPXV infection, many of the lymphocyte populations we had 
previously examined showed decreased total cell numbers (Figure 20D-H). These data 
indicated that macrophages are responsible not only for the recruitment of NK cells but 
also other lymphocyte populations. 
  
Macrophages and Chemokines Function Separately to Recruit NK Cells 
Since macrophages produce many inflammatory cytokines and chemokines, 
including CXCL9 and CXCL10 (134, 135), it seemed likely that they were responsible 
for the CXCR3-mediated NK cell recruitment. Surprisingly, however, when we examined 
chemokine expression in the draining LNs of mice treated either with control liposomes 
containing PBS or liposomes containing clodronate, we found no decrease in transcripts 
for Cxcl9 or Cxcl10 (Figure 21A, 21B). As a control for liposome injection, we observed 
little to no difference in transcripts for Ccl19 and Ccl21 in the non-draining and draining 
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LNs (Figure 21C, 21D). These data suggest that NK cells are being recruited through two 
independent mechanisms and that chemokine-mediated recruitment may be necessary but 
not sufficient for NK cell recruitment following CPXV infection. 
 
Control of Viral Replication in Depleted Systems 
To assess the impact of decreased numbers of NK cells in the draining LN on 
control of CPXV infection, we again took advantage of CXCR3-deficient mice, where 
NK cell recruitment following CPXV infection is diminished but not eliminated. We also 
measured viral replication in CXCR3-deficient mice treated with control or NK cell 
depleting antibody (Figure 22A). When control antibody was administered to both wild-
type and CXCR3-deficient mice, viral replication in the draining LNs was similar (Figure 
22B). When these mice were systemically depleted of NK cells, the viral replication was 
increased in the draining LNs of both of these mice to similar extents. When examining 
viral replication in the lung and spleen, we did not see any significant difference between 
wild-type and CXCR3-deficient mice with or without NK cell neutralizing antibody 
(Figure 22C, 22D). These data suggest that even the decreased NK cell population such 
as that in CXCR3-deficient mice was sufficient to control local replication and prevent 
systemic dissemination. 
Following clodronate-loaded liposome treatment and subsequent infection there 
were even fewer NK cells present in the draining LN than in the CXCR3-deficient mice. 
We also speculated that because macrophages are preferentially infected following 
cutaneous VV infection in the draining LN, that depletion of macrophages could lead to 
removal of the primary site of viral replication (132). To examine the impact of lack of 
these populations on viral control, we assessed whether there was a local decrease in viral 
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burden in the draining LN and increase in systemic spread following macrophage 
depletion. Even in the absence of macrophages and with minimal numbers of NK cells, 
viral burden in the draining LN was equivalent in mice pre-treated with either PBS- or 
clodronate-loaded liposomes (Figure 23A). These data indicated that replication of 
CPXV in the draining LN was unimpaired in the absence of macrophages suggesting an 
ability for CPXV to infect and replicate in another LN resident cell. Additionally, in 
contrast to our hypothesis that a lack of macrophages would result in systemic 
dissemination, there was no significant increase in viral burden in the lungs or spleens of 
macrophage depleted mice (Figure 23B, 23C). It seems then that removing the 
preferential target cell of CPXV did not impact viral replication or spread. Additionally, 
even the minimal number of NK cells present in the draining LN following macrophage 
depletion and CPXV infection was sufficient to control viral replication and spread. 
 
Discussion 
 There are multiple factors required for NK cell recruitment to the draining lymph 
node following CPXV infection. Innate lymphocyte detection of infection results in 
cytokine induction, and we have dramatically demonstrated a lack of NK cell recruitment 
in IFN!R1-deficient mice.  Mice that have selectively been depleted of DCs or 
macrophages demonstrate decreased NK cell recruitment indicating their importance for 
this process. Although it appears that NK recruitment requires both IFN-! induced 
chemokine expression, including CXCL9 and CXCL10, and SCS macrophages, these 
pathways are not immediately linked. Finally, despite decreased NK cell recruitment, 
viral replication was still controlled by the minimal numbers of NK cells still founding in 
the draining LN following CPXV infection. 
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 It is well known that there are multiple interactions between DCs and NK cells 
including DC mediated differentiation, maturation and activation of NK cells (44, 45, 53, 
117, 136, 137). Recent studies also attempt to extend these interactions to include the 
requirement of DCs for NK cell recruitment. During MCMV infection, when NK cells 
trafficked into the white pulp of the spleen, they were preferentially associated with 
ERTR7 expressing cells that were also associated with DCs (109). A more direct study 
demonstrated that footpad injection of in vitro LPS matured DCs was sufficient to recruit 
NK cells to the draining LN (107). Therefore, as these studies indicate a role for DCs in 
NK cell recruitment, they appear to further contribute to the complex and established 
dynamic crosstalk between these two subsets.  
To our surprise, evidence in support the importance of DCs upstream of NK cell 
recruitment appeared to be lacking following CPXV infection. Combining the results of 
the CD11c-DTR transgenic system and BMDC complementation, DCs appeared to be 
necessary but not sufficient for NK cell recruitment. However, these results remain 
confounded by the absence of a good model system of DC deficiency that could be 
complemented with an external source of DCs. While NK cells were not recruited in 
CCR7-deficient mice, the cell populations and architecture of the lymph node are highly 
distorted in these mice, leading to poor ability to prime a cellular immune response (99). 
Additionally, given the random induction of autoimmunity in these deficient mice and 
resultant lymphadenopathy, data collected in this system cannot be fully interpreted (99, 
122, 123). There are also caveats when examining the diphtheria toxin treated CD11c-
DTR transgenic mice. There is ectopic expression of CD11c expression on non-DC 
lymphocyte populations, leading to their ablation following diphtheria toxin treatment 
along with conventional DCs (133). Furthermore, depletion of DCs in this system is not 
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complete as only 85%-90% of DCs are depleted (138). Additionally, even at low doses of 
diphtheria toxin, mice became ill and died within 6 days of injection as has been reported 
in the literature (138). Attempts to restore NK cell recruitment by complementing DC 
deficiency in these mice, even when examining early time points, were ultimately 
unsuccessful in our hands. Given these off target effects of diphtheria toxin in CD11c-
DTR mice, data collected in this background can be difficult to interpret.  
With these results in mind, we re-examined previously collected data for further 
evidence that DCs might be involved in NK cell recruitment. We found that there was 
little to no increase in migratory DC populations in the draining LN of C56BL/6 CPXV 
infected mice. Additionally, we did not observe NK cell recruitment defects when 
examining BATF3-deficient mice, indicating the cross-presenting DC population was 
also not involved in recruitment. The only DC population in which we observed 
expansion in the draining LN following CPXV infection was the LN resident DC 
population. This population is seeded by the migration of monocytes into lymphoid 
organs and their differentiation into DCs (115). However, it remains unknown if there is a 
monocyte influx and differentiation into DCs in the draining LN following CPXV 
infection. 
The role of macrophages in NK cell recruitment is a relatively new idea, which 
was published while we confirming our results. In several studies, macrophages were 
shown to be important for NK cell recruitment to the CD169+ SCS macrophage area in 
response to both bacterial and viral pathogens (131, 139, 140). When liposomes 
encapsulating clodronate are injected in the footpad, NK cells no longer localize to the 
SCS region and are not activated in response to MVA (140). In agreement with these 
data, ablation of the CD169+ macrophage population followed by CPXV footpad 
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infection resulted in decreased NK cell recruitment to the draining LN. These data 
suggest that macrophages are involved in important upstream events which lead to NK 
cell recruitment, including the detection of infection and direction of adaptive immune 
response priming.  
A recently published report found that macrophages are important for inducing 
innate effector cell production of IFN-!. These cells included “innate” CD8+ T cells, 
NKT cells and !% T cells. When the CD169+ macrophages were depleted, the protective 
ability of these innate effector cells is reduced in response to Pseudomonas aeruginosa 
(131). The IFN-! produced by these innate responders is important for controlling 
bacterial load in the draining LN and preventing spread to the blood. However, when we 
examined viral burden in mice that had been pre-treated with clodronate-loaded 
liposomes prior to CPXV infection, we did not see a substantial increase in draining LN 
titers, nor in titers at more distal sites in which we had previously seen spread following 
systemic NK cell depletion. These data indicate that there are differential responses to 
bacterial and viral infections by both NK cells and other innate immune lymphocytes. 
 There are several potential explanations as to why an increase in viral burden was 
not observed following macrophage depletion. It is possible that the minimal number of 
NK cells and the innate effector response were sufficient to suppress viral replication to a 
similar extent as in unmanipulated mice. In contrast to systemic NK cell depletion, where 
we did see an increase in viral burden both locally and distantly, NK cells in the draining 
LN were significantly reduced in comparison to macrophage depleted and infected mice. 
We have also observed this trend of viral control with minimal numbers of NK cells in 
CXCR3-deficient mice. Only after NK cell depletion in the CXCR3-deficient mice was 
there increased viral burden in the draining LN. While the CXCR3 draining LN did 
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contain a larger population of NK cells than the clodronate-loaded liposome treated LNs, 
it is possible that even the very small numbers of NK cells present in these conditions are 
sufficient for viral control. Alternately, as it appears that orthopoxviruses preferentially 
infect macrophages (132), it is possible that following macrophage depletion, viral 
particles traffic through the lymph to the next LN (the inguinal or thoractic LNs) instead 
of the blood. Future work to interrogate the mechanism of macrophage mediated NK cell 
recruitment could examine viral burden in these LNs. Given similar viral burdens in the 
draining LN after control- and clodronate-loaded liposome treatment, it appeared that 
another cell is infected in the absence of macrophages. Perhaps this alternately infected 
cell type does not raise a strong innate anti-viral immune response resulting in a 
diminished inflammatory response and lymphocyte recruitment. 
Recognition of CPXV infection and induction of an inflammatory response 
including NK cell recruitment appears to be multifactorial and complex. Given the 
inability of BMDCs to restore NK cell recruitment and the depletion of SCS 
macrophages in diphtheria toxin treated CD11c-DTR transgenic mice, it appears that DCs 
are insufficient to induce NK cell recruitment following CPXV infection. While depletion 
of macrophages resulted in a decrease in the number of NK cells recruited, it did not 
result in a decrease of IFN-! induced chemokine expression or increased local or 
systemic viral burden. These data suggest a two step model for NK cell recruitment, 
where chemokines are induced following infection and SCS macrophages provide an 
unknown second signal. 
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Figure 14: IFN-!  is required for NK cell recruitment and inflammatory chemokine 
expression. 
(A) Age and sex matched IFN!R1-deficient and C57BL/6 mice were inoculated in the 
footpad with 1.5x106 pfu/mouse and at indicated time points, lymphocytes from the non-
draining and draining LNs were isolated, stained and analyzed by flow cytometry. Total 
NK cells (NK1.1+CD3-CD19-) were identified. A representative result of 2 independent 
experiments is shown. (B-E) Age and sex matched C57BL/6 mice were treated 2 days 
prior to infection with 250µg of control (PIP) or IFN-! neutralizing (H22) antibody. (B) 
Total NK cells (NK1.1+CD3-CD19-) were identified. The graph depicts the average of 3 
independent experiments. (C-F) Transcript analysis of Cxcl9, Cxcl10, Ccl19 and Ccl21 
was analyzed by quantitative PCR. The graph represents the average of data from 2 
mice/group from 3 independent experiments. Unpaired Student’s t-test: (*) = p < 0.05; 
(**) = p < 0.005; (***) = p < 0.0005; (****) = p < 0.0001. 
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Figure 15: CCR7 is extrinsically required for NK cell recruitment to the draining 
LN following CPXV infection. 
(A) Age and sex matched CCR7-deficient and C57BL/6 mice were infected with CPXV 
and NK cell recruitment was monitored as before. The graph depicts the average of 3 
independent experiments. (B) C57BL/6 (CD45.1) and CCR7-/- (CD45.2) splenocytes 
were isolated and enriched by negative selection before being CFSE labeled, mixed and 
co-transferred intravenously into C57BL/6 mice. One day after transfer, mice were 
infected as before and NK cell (NK1.1+CD3-CD19-) populations were examined at 
indicated time points. To analyze the recruitment in this system, the total number of 
recruited wild-type or chemokine knockout NK cells at 2 and 3 dpi were compared 
relative to the initial time point at 1 dpi. A representative result of 3 independent 
experiments is shown. 
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Figure 16: NK cell recruitment is defective in CPXV infected CD11c-DTR 
transgenic mice. 
(A) Age and sex matched CD11c-DTR+/- and C57BL/6 mice were treated with 20, 10 and 
5 ng/g body weight of diphtheria toxin. Lymphoid (A, C, E) and splenic (B, D, F) total 
NK cells (A, B), total macrophages (C, D) and total conventional DCs (E, F) were 
analyzed by flow cytometry. (G) For NK cell recruitment, a dose of 5 ng/g body weight 
was chosen and administered 1 day prior to infection with CPXV. At 1 and 2 dpi, LNs 
were harvested, treated with Liberase TL, and lymphocytes were isolated, stained and 
analyzed by flow cytometry. The graph depicts the average of 3 independent 
experiments. 
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Figure 17: Inconsistencies in CCR7-deficient mice. 
(A) Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the top of 
the foot of CCR7-deficient mice. LNs were isolated 1 day later and treated with Liberase 
TL following which lymphocytes were isolated, stained and analyzed by flow cytometry. 
(B) Age and sex matched CCR7-deficient and C57BL/6 mice were infected and NK cell 
recruitment was monitored as before. The graph depicts the average of 2 independent 
experiments. (C) Total cells from the popliteal LNs from 3-4 unmanipulated CCR7-
deficient mice per age group and 1 unmanipulated C57BL/6 mouse were counted using 
trypan blue exclusion. CCR7-deficient mice were examined at 2, 3 and 4 months of age 
and from C57BL/6 mice at 2 months of age. Each symbol represents 1 popliteal LN from 
a mouse, with both popliteal LNs represented on the graph.  
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Figure 18: BMDCs do not complement NK cell recruitment defects seen in CD11c-
DTR transgenic mice following CPXV infection. 
C57BL/6 and CD11c-DTR transgenic mice were age and sex matched and treated with 5 
ng/g body weight of diphtheria toxin 1 day prior to injection of BMDCs and CPXV 
infection. Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the 
top of the foot while CPXV was injected in the bottom of the footpad of diphtheria toxin 
treated CD11c-DTR mice and C57Bl/6 mice. LNs were isolated 1 day later and treated 
with Liberase TL following which lymphocytes were isolated, stained and analyzed by 
flow cytometry. (A) Percent and (B) total donor derived BMDCs 
(CD11c+MHCIIhighCFSE+) and (C) total NK cells (NK1.1+CD3-CD19-) were assessed 
and graphed. The graph represents 1 mouse for BMDC injected alone and CXPV injected 
alone while BMDC and CPXV injected in the same foot represent the average 2 mice for 
both CD11c-DTR and C57BL/6 mice. 
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Figure 19: BATF3 deficiency does not affect NK cell trafficking following CPXV 
infection. 
Age and sex matched BATF3-deficient mice on a 129S6/SVEV background and 
129S6/SVEV control mice were infected as previously described. Draining and non-
draining LNs were isolated at 2 and 3 dpi and lymphocytes were isolated, stained and 
assessed by flow cytometry for (A) percent and (B) total NK cells (NK1.1+CD3-CD19-) 
as before. The graph depicts the average of 2 independent mice. 
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Figure 20: Macrophage depletion leads to decreased lymphocyte recruitment. 
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL 
of either PBS- or clodronate-loaded liposomes. (A) A representative section of a 
macrophage depleted draining LNs isolated 3 hpi following CPXV infection is shown 
following staining with CD169+ (PE), CD3+ (FITC) and DAPI. The (B) total macrophage 
population (F4/80+CD11b+), (C) total NK cell population (NK1.1+CD3-CD19-), (D) total 
neutrophil population (Ly6G+SSC+), (E) total migratory DC population 
(CD11c+MHCIIhigh), (F) total LN resident DC population (CD11c+MHCII+), (G) total T 
cell population (CD3+CD19-NK1.1-) and (H) total B cell population (CD19+CD3-NK1.1-) 
were observed by flow cytometry 3 dpi. The graph depicts the average of 2 mice from 2 
independent experiments. Figure 1A was contributed by Dorothy Sojka. 
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Figure 21: Inflammatory chemokine transcripts are unaffected by macrophage 
depletion. 
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL 
of either PBS- or clodronate-loaded liposomes. Transcript analysis of (A) Cxcl9, (B) 
Cxcl10, (C) Ccl19 and (D) Ccl21 was analyzed by quantitative PCR. The graph 
represents the average of data from 2 independent experiments with 3 mice/group for 
each experiment. Unpaired Student’s t-test: (*) = p < 0.05. 
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Figure 22: NK cells control CPXV replication in CXCR3-deficient mice. 
Age and sex matched CXCR3-deficient and C57BL/6 mice were injected IP with 200µg 
control (mAR) or PK136 antibody 2 days prior to infection. (A) NK cell depletion was 
confirmed in the non-draining LN at 3 dpi. Quantitative PCR was used to assess viral 
burden in the (B) LNs, (C) lungs (D) and spleens. CPXV copy number was normalized to 
$-actin copy numbers and then multiplied by 1000. Symbols indicate individual mice and 
lines indicate the mean. N= 4 to 7 mice/group were analyzed for each time point. 
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Figure 23: Macrophage depletion does not impact CPXV replication. 
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL 
of either PBS- or clodronate-loaded liposomes. Quantitative PCR was used to assess viral 
burden in the (A) LNs, (B) lungs (C) and spleens at 3 dpi. CPXV copy number was 
normalized to $-actin copy numbers and then multiplied by 1000. Symbols indicate 
individual mice and lines indicate the mean. N= 5 mice/group were analyzed for each 
time point. 
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CHAPTER 6: 
Comparison of Cowpox Virus and Vaccinia Virus Footpad Infection 
 104 
Vaccinia virus has been used extensively as a prototypical model for 
orthopoxviral infection in both in vitro and in vivo studies. To better understand whether 
CPXV acts like a typical or abnormal orthopoxvirus for NK cell recruitment studies, we 
used VV as a control. This chapter describes the host response to VV footpad infection, 
with particular regard to NK cell recruitment. 
 
Vaccinia Virus Effectively Infects Both the Draining LN and Spleen Following 
Footpad Inoculation. 
Viral spread and replication following CPXV or VV infection was similar, but 
had distinct differences. When VV was inoculated in the footpads of C57BL/6 mice using 
the same dose used for CPXV infections, VV spread to and replicated in the draining LN. 
Titers for both viruses increased with similar kinetics between 1 and 3 dpi (Figure 24A).  
However, following VV infection LN titers did not reach the same levels and resolved 
faster than titers following CPXV inoculation. Titers were reduced to the limit of 
detection by 6 dpi following VV infection whereas CPXV titers were not resolved until 
9dpi. Thus CPXV was capable of surviving and replicating longer in the draining LN 
than VV. Additionally, no titers were found for either virus in the liver by traditional 
plaque assays (data not shown). 
While productive infection of the draining LN appeared to be similar when 
comparing the two viruses, the same was not true for spread to the spleen. Following VV 
inoculation, titers were found above the limit of detection in the spleen 2 dpi whereas 
titers were barely above or were at the limit of detection following CPXV inoculation 
(Figure 24B). In addition, VV replicated in the spleen, peaking somewhere between 3 and 
6 dpi reaching titers 2-logs greater than the limit of detection. Titers were decreased at 6 
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dpi but we did not determine the day at which VV infection resolved. Taken together, 
these data show that CPXV and VV replicate similarly, though with different kinetics, in 
the draining LN and that VV, but not CPXV, is capable of spreading to and replicating 
within the spleen.  
 
CPXV and VV Cause Similar Lymphocyte Population Expansion in the Draining 
LN 
Cowpox and Vaccina virus infection caused lymphadenopathy resulting from an 
expansion of the same lymphocyte populations in the draining LNs following footpad 
infection. Both macrophage and neutrophil populations were increased at early times 
following VV and CPXV inoculation (Figure 25A, 25B). The total neutrophil population 
expansion was equivalent following either orthopoxviral infection but increase in the 
macrophage population was slightly greater following VV inoculation at all time points 
observed. In agreement with data generated following CPXV infection, following VV 
infection we found little to no increase in the migratory DC population but an expanded 
LN resident DC population (Figure 25C, 25D). We also observed large increases in both 
T and B cell numbers, again with the total populations being larger following VV 
inoculation (Figure 25E, 25F). Most importantly, we determined that there was a large 
increase in the NK cell population following VV inoculation, which occurred with 
slightly faster kinetics and persisted for a similar length of time following CPXV 
infection (Figure 25G). All together, these data suggest that CPXV and VV prime similar 
recruitment responses of lymphocytic populations, though VV may less efficiently inhibit 
recruitment of lymphocyte populations resulting in a faster and more robust expansion of 
macrophages, NK and T cells. 
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When we examined the surface phenotype of NK cells found in the draining LN 
following VV footpad inoculation, we found that they expressed markers typical of 
splenic but not thymic NK cells. NK cells isolated from the spleen and draining LN 
displayed identical expression of Mac-1 (CD11b), DX5, L-selectin (CD62L), NKG2D, 
the Ly49 family (ADCIFH) and CD94 (Figure 26A-F). Similar to following CPXV 
infection, expression of Mac-1 (CD11b) and L-selectin (CD62L) was different on NK 
cells isolated from the non-draining and draining LN. Again, markers of thymic NK cells 
were not found on NK cells isolated from the draining LN following VV infection 
(Figure 26G, 27H). NK cells isolated from the draining LN following either CPXV or 
VV infection expressed the same markers with the same intensity as NK cells derived 
from the spleen, suggesting that the same subset of NK cells are being recruited 
following either infection. These data suggest that the NK cell population in the draining 
LN was recruited rather than the result of in situ proliferation.  
 
NK Cells Are Recruited by the Same Mechanism Following Infection With Either 
CPXV or VV 
In agreement with the data generated following CPXV inoculation, VV also 
induced NK cell expansion in a pertussis toxin sensitive manner. When we transferred 
NK cells pre-treated with PBS in vitro into congenic mice, we found that these cells were 
again accumulated over time in the draining LN following VV inoculation. Recruitment 
of PBS pre-treated adoptively transferred NK cells appeared stronger following VV 
infection than CPXV infection, as total cell numbers of these transferred NK cells were 
greater at both 2 and 3 dpi following VV infection (Figure 27A, 27B). When NK cells 
that had been pre-treated in vitro with pertussis toxin were co-transferred at the same 
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time, they did not accumulate in the draining LN. Taken together, these data indicate that 
NK cells recruitment was pertussis toxin sensitive and therefore required GPCRs 
following both CPXV and VV infection. 
When examining chemokine transcripts in the draining LN following VV 
infection, we observed differential upregulation of some chemokine transcripts. Some 
transcripts we observed to be up-regulated following VV but not CPXV inoculation 
including Cxcl1, Cxcl2 and Cxcl5 at 1 dpi (Figure 28). These chemokines have been 
implicated to affect neutrophils trafficking (141-143). It also appeared that Ccl24, which 
has been shown to be important in eosinophils, basophils, and T cells (144), was 
expressed earlier and then diminished more immediately following VV infection, 
whereas CPXV induced prolonged expression of this transcript. There were also 
differences in the abundance of transcripts for Ccl20, which has been shown to be 
important a variety of lymphocytes including T cells, NKT cells and activated B cells, 
which appeared to have a delay in expression following VV infection. These data indicate 
that there is up-regulation of additional chemokines during VV infection that were not 
observed following infection with CPXV. 
Expression of chemokine transcripts up-regulated during VV infection was fairly 
similar to that following CPXV infection. However, there were several important 
differences in the intensity of chemokine up-regulation following CPXV and VV 
infection. When examining transcripts for Ccl2 and Ccl7, we observed more abundant 
transcripts following VV infection at all time points observed in comparison to CPXV 
infection. Also, the IFN-! induced transcripts Cxcl9, Cxcl10, and Cxcl11 were more 
highly induced and with faster kinetics following VV inoculation. Meanwhile, some 
transcripts, such as those for Ccl3 and Ccl4, were nearly identical following either 
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infection. The inflammatory chemokine transcript expression profile corresponded highly 
with the larger increase in lymphocyte populations following VV infection in the draining 
LN. These data again suggest that CPXV better inhibits the inflammatory response 
including inflammatory chemokine expression than VV. This may permit a faster and 
more robust accumulation of lymphocytes in the draining LN following VV inoculation.  
 To determine whether recruitment of NK cells following VV infection required 
the same chemokine receptors as following CPXV infection, we examined NK cell 
recruitment in chemokine receptor-deficient mice. In mice deficient for either CCR2 or 
CCR5, there was a slight defect at 2 dpi but at 3 dpi NK cell recruitment was equivalent 
in wild-type and chemokine receptor-deficient mice following VV infection (Figure 29A, 
29B). These data were comparable to the requirement for CCR2 and CCR5 following 
CPXV infection at 3 dpi. Mice that were deficient for CXCR3 showed a defect in NK cell 
recruitment at both 2 and 3 dpi following both CPXV and VV infection (Figure 29C).  As 
expected, NK cell recruitment following VV, like CPXV infection, required NK cell 
intrinsic expression of CXCR3 during adoptive transfer experiments (Figure 29D). These 
data suggest that NK cells required similar chemokine receptors for recruitment 
following infection with either CPXV or VV, providing further evidence that the same 
NK cell population is recruited using related mechanisms following infection with either 
orthopoxvirus. 
 
Upstream Signaling Appears to Be Comparable Following Either CPXV or VV 
Infection 
As discussed in Chapter 5, we initially hypothesized that DCs were important for 
NK cell recruitment following orthopoxviral infection. It appeared that DC populations 
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were fairly equivalently following either CPXV or VV infection, with a slight elevation 
in total resident DC numbers following VV infection at 6 dpi. However, this time point is 
well beyond the peak of NK cell expansion in the draining LN. Concurrent to testing the 
requirement for DCs upstream of CPXV infection, we also examined if DCs could 
complement NK cell trafficking defects following VV infection in DC depleted mice. 
Again we saw a defect in trafficking of injected BMDCs when VV concurrently injected 
in the CD11c-DTR depleted mice (Figure 30A, 30B). Interestingly, the defect in DC 
trafficking in the presence of VV was not observed in the C57BL/6 mice. Additionally, 
even with some DCs trafficking to the draining LN, recruitment of NK cells was not 
observed when BMDCs were co-injected in the CD11c-DTR mice (Figure 30C). These 
data further indicate that DCs are not sufficient for recruitment of NK cells following 
both CPXV and VV infection. 
  
Discussion 
Here we demonstrate that similar lymphocyte populations accumulate in the 
draining LN during both CPXV and VV infection. There was a trend towards a more 
robust recruitment of some but not all lymphocytes following VV infection suggesting 
that CPXV inhibits lymphocyte recruitment more than VV. This increased lymphocyte 
recruitment correlated with the induction of more inflammatory chemokine transcripts 
during VV infection. The NK cell population expanded with faster kinetics following VV 
infection, but the mechanism of recruitment and origin of recruited cells was the same. 
Although, it has been well established that VV can subvert the immune system, 
immunocompetent hosts routinely clear infection. While VV has been used extensively to 
study immunomodulation of the host immune system by orthopoxviruses, it does not 
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contain the extensive range of immunomodulatory ORFs found in CPXV (16, 23, 24). 
While CPXV and VV share many homologous ORFs responsible for the viral life cycle 
and immunomodulation, CPXV encodes many completely unique ORFs, mostly in 
regions of its genome associated with immunomodulation and host adaptation. Therefore, 
it was important to determine if the immune response to both viruses was similar or if 
CPXV was more immunosuppressive as a consequence of these unique ORFs. We 
assessed viral titers, viral spread and lymphocyte recruitment to the draining LN 
following infection of mice with both viruses. Our data thus far indicate that CPXV and 
VV very similarly recruited lymphocytes and replicated to similar titers following 
infection.   
In contrast to CPXV footpad infection, VV was capable of spreading to and 
replicating within the spleen. This raises the possibility that VV may spread to other 
distant sites from the draining LN, but a systematic survey of other organs has not been 
performed. The increased viral spread of VV was surprising given the induction of a 
more robust recruitment of lymphocytes following VV infection and because viral titers 
in the LN did not reach the same levels as titers following CPXV infection. Secondary 
viral spread is thought to follow sufficient replication in a primary organ, therefore 
although viral burden in the draining LN following VV infection did not reach levels 
found following CPXV infection, it was sufficient for viral spread. One possible 
explanation for increased viral dissemination is that VV may have a broader cellular 
tropism than CPXV. Once a few viral particles enter the circulation or the lymph, they 
could establish productive foci of infection elsewhere, such as the spleen. However, this 
hypothesis seems unlikely as CPXV has been shown to have one of the broadest host 
ranges of the orthopoxviruses and therefore the ability to infect many different host cells 
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(145). An alternate hypothesis is that VV recruits a lymphocyte population that is not 
recruited following CPXV that traffics from the infected LN to the spleen. It is currently 
unclear why VV, but not CPXV, is able to spread to and replicate within the spleen. 
Although both CPXV and VV caused lymphadenopathy and influxes of the same 
types of lymphocytes, VV stimulated an earlier and sometimes greater expansion of some 
lymphocytes, including macrophages, NK cells and T cells. These results suggest that 
CPXV more strongly attenuated inflammatory lymphocyte recruitment than VV, 
particularly at early times following infection. Again, transcriptional profiles of 
inflammatory chemokines lend support to this hypothesis, including expression of Ccl24, 
Cxcl1, Cxcl2, and Cxcl5 that was only seen following VV infection. CXCL1, CXCL2 and 
CXCL5 all bind only CXCR2, which has been implicated in neutrophil recruitment 
following infection with several bacterial pathogens (141-143). Additionally, as 
macrophages and neutrophils secrete CXCL1 and CXCL2, the expression of these 
chemokines and subsequent recruitment of additional macrophages and neutrophils could 
be acting in a positive feedback loop. Eosinophils express CCR3 (144), the receptor for 
CCL24. However we did not examine this population so it is unknown whether it is 
differentially recruited. While CCL24 is important during parasitic infections and renders 
CD4+ T cells more sensitive to human immunodeficiency virus infection, its role 
following orthopoxvirus infection has not been determined (146, 147). In addition, 
chemokine transcripts that have been previously implicated in NK cell recruitment 
following CPXV and other bacterial and viral pathogens, including Ccl2, Ccl7, Cxcl9, 
Cxcl10, and Cxcl11, also had higher induction following VV infection of the draining 
LN.  
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Despite these slight differences, it appeared that the course of infection following 
either CPXV or VV was very similar. There was a notably slight delay in NK cell 
recruitment at early times following CPXV infection. NK cells isolated from the draining 
LN following infection with CPXV and VV had identical expression of NK cell surface 
markers which were typical of splenic NK cells. We observed a slight defect at 2 dpi in 
the CCR2 and CCR5 defect following VV infection, which may be linked to the high 
levels of Ccl2 induction. Again, NK cell recruitment did not appear to occur in a CCR2- 
or CCR5-dependent manner at 3 dpi, but in a CXCR3 cell intrinsic manner for both 
viruses. Overall, it appears that though VV recruitment of lymphocytes was more robust 
and faster, CPXV infection was similar to the prototypical model of orthopoxviral 
infections. We can therefore conclude that NK cell recruitment following infection with 
orthopoxvirus family members is likely to be mediated by similar or identical 
mechanisms.  
After footpad inoculation with either CPXV or VV, lymphadenopathy resulted 
from similar recruitment of lymphocyte populations. These data also indicated that 
recruitment of the splenic NK cells to the draining LN is mediated by same chemokines 
and chemokine receptors. Additionally, DC complementation was also insufficient to 
restore NK cell trafficking suggesting an upstream requirement for macrophages in NK 
cell trafficking following VV infection. Taken together, these data indicated that CPXV 
and VV induce a very similar host response following footpad infection. 
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Figure 24: VV establishes infection in the draining LN and spleen following footpad 
inoculation. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu of VV in the footpad 
and at indicated time points, organs were removed and viral titers were assessed in the 
draining LN (A) and spleen (B) by plaque assay. Dotted lines indicate the limit of 
detection by the assay. Symbols indicate individual mice and the mean and SEM are 
depicted. N= 4 to 5 mice/group were analyzed for each time point. 
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Figure 25: Comparative kinetics of innate and adaptive lymphocyte expansion 
following CPXV or VV footpad infection. 
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106 
pfu/mouse of VV and at indicated time points, lymphocytes from the non-draining and 
draining LNs were isolated. (A-D)  LNs were diced and incubated in Liberase TL before 
lymphocytes were isolated, stained and analyzed by flow cytometry. (E-G) Lymphocytes 
were isolated, stained and analyzed by flow cytometry and (A) total macrophages 
(F4/80+CD11b+), (B) total neutrophils (Ly6G+SSC+), (C) total migratory DCs 
(CD11c+MHCIIhigh), (D) total LN resident DCs (CD11c+MHCII+), (E) total T cells 
(CD3+CD19-NK1.1-), (F) total B cells (CD19+CD3-NK1.1-) and (G) total NK cells 
(NK1.1+CD3-CD19-) were identified. (A-F) Graphs depicting the average of 3 
independent experiments are shown. (G) The graphs depict average of n=6 independent 
experiments (18 hpi), n=14 independent experiments (1 dpi), n=3 independent 
experiments (36hpi), n=8 independent experiments (2 & 3 dpi), and n=2 independent 
experiments (6 & 9dpi). 
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Figure 26: NK cells isolated from the draining LN following VV infection express 
markers of splenic but not thymic NK cell subsets. 
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the 
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained. 
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) Mac-1 
(CD11b) (B) pan-Ly49 family receptors (Ly49ADCIFH), (C) L-selectin (CD62L), (D) 
DX5 (CX5), (E) CD94, (F) NKG2D, (G) IL-7R" (CD127) and (H) integrin "E (CD103) 
was determined. Surface staining remained the same when observing NK cells isolated 
from these organs at 2 and 3 dpi. 
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Figure 27: NK expansion in the draining LN is pertussis toxin sensitive following 
VV infection. 
Splenocytes isolated from congenic C57BL/6 (CD45.2) and B6.LY5.2 (CD45.1) mice 
were pre-treated in vivo with PBS or pertussis toxin for 2 hours at 37°C, 5% CO2 before 
being washed, CFSE labeled, mixed and co-injected IV into C57BL/6 mice. Immediately 
following adoptive transfer, the mice were infected with 1.5x106 pfu of VV in the 
footpad. At the indicated time points, LNs were harvested and NK cells (NK1.1+CD3-
CD19-) were identified. Host NK cell recruitment (CFSE-) (A) or donor NK cell 
recruitment (CFSE+) (B) is shown over time. Data are representative of 2 independent 
experiments. 
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Figure 28: Inflammatory chemokine transcripts are up-regulated following VV 
infection. 
RNA transcript levels were assessed in C57BL/6 mice infected with 1.5x106 pfu of VV in 
the footpad at indicated time points by multiplex gene expression analysis. LNs from 3 
independently infected mice were isolated and lysates from either the non-draining or 
draining LN were generated, run in triplicate, and chemokine transcripts normalized to 
the control Hprt1 transcript for each sample. The fold change indicated in each square 
depicts the average transcript level in the draining LN relative to the non-draining LN. 
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Figure 29: NK cell recruitment occurs in the absence of CCR2 and CCR5 but 
intrinsically requires CXCR3 expression following VV infection. 
Age and sex matched C57BL/6 and (A) CCR2-deficient, (B) CCR5-deficient or (C) 
CXCR3-deficient mice were infected with 1.5x106 pfu of VV. At indicated time points, 
lymphocytes from the non-draining and draining LNs were isolated, stained and analyzed 
by flow cytometry. Total NK cells (NK1.1+CD3-CD19-) were identified. The graph 
depicts the average of 3 independent experiments. (D) C57BL/6 (CD45.1) and CXCR3-/- 
(CD45.2) splenocytes were isolated and enriched by negative selection before being 
CFSE labeled, mixed and co-transferred intravenously into C57BL/6 mice. 1 day after the 
transfer, mice were infected as before and NK cell populations were examined at 
indicated time points. To analyze the recruitment in this system, the total number of 
recruited wild-type or chemokine knockout NK cells at 2 and 3 dpi were compared 
relative to the initial time point at 1 dpi. A representative result of 3 independent 
experiments is shown. 
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Figure 30: BMDCs do not complement NK cell recruitment defects seen in CD11c-
DTR transgenic mice following VV infection. 
Age and sex matched C57BL/6 and CD11c-DTR transgenic mice were treated with 5 
ng/g body weight of diphtheria toxin 1 day prior to injection of BMDCs and VV 
infection. Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the 
top of the foot while CPXV was injected in the bottom of the footpad of diphtheria toxin 
treated CD11c-DTR mice and C57Bl/6 mice. LNs were isolated 1 day later and treated 
with Liberase TL following which lymphocytes were isolated, stained and analyzed by 
flow cytometry. (A) Percent and (B) total donor derived BMDCs 
(CD11c+MHCIIhighCFSE+) and (C) total NK cells (NK1.1+CD3-CD19-) were assessed 
and graphed. The graph represents 1 mouse for BMDC injected alone and CXPV injected 
alone while BMDC and CPXV injected in the same foot represent the average 2 mice for 
both CD11c-DTR and C57BL/6 mice. 
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CHAPTER 7: 
Cowpox Virus Mediated-Inhibition of NK Cell Activation 
 128 
During the initial analysis of NK cell recruitment, it became apparent that NK 
cells recruited to the draining LN following CPXV infection were not producing IFN-!. 
This cytokine is an important mediator of the inflammatory response and contributes to 
priming of a TH1 adaptive immune response (54, 107, 131, 137, 148). NK cells are one of 
the major producers of IFN-! at early times following infection. This chapter describes 
the inhibition of NK cells by CPXV in a footpad model of infection. 
 
NK Cells Recruited by CPXV Do Not Produce IFN-! 
 
 One of the primary functions of NK cells aside from target cell lysis is production 
of cytokines, including IFN-! which primes a TH1 T cell response (54, 107, 148). It was 
demonstrated that following ECTV infection, NK cells producing IFN-! were recruited to 
the draining LN at early times following infection (80, 81). With these studies informing 
our experiments, NK cells recruited to the draining LN were examined for IFN-! 
following CPXV footpad inoculation. Surprisingly, at no time point studied did we 
observe NK cells producing IFN-! (Figure 31A). In contrast to this CPXV specific 
finding, C57BL/6 mice inoculated with either VV or MCMV recruited IFN-! producing 
NK cells in the draining LN (Figure 31A, 31B). Production of IFN-! peaked between 1 
and 2 dpi for MCMV and between 2 and 3 dpi for VV, time points where there was no 
IFN-! observed following CPXV infection. 
 Since it was possible that the lack of IFN-! production by NK cells following 
CPXV infection may have been a consequence of insufficient infectious dose, we 
examined a range of CPXV doses to determine if it was possible to induce IFN-! 
production under any circumstances. However, IFN-! production by NK cells did not 
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occur when mice were inoculated with a wide range of doses, from 3.75 x 103 pfu/mouse 
to 3.75 x 106 pfu/mouse (Figure 32A). In contrast, we observed IFN-! producing NK 
cells following infection with VV beginning at 3.75 x 104 pfu/mouse, with increased 
IFN-! production directly correlating with increased infectious dose (Figure 32B). In 
order to simultaneously study both NK cell recruitment and IFN-! inhibition by CPXV, 
all subsequent experiments were performed using a dose of 1.5 x106 pfu/mouse. 
 
Cytokine Production in the Draining LN Following CPXV and VV Infection 
 NK cells are one of the primary sources of early IFN-! production following 
infection by a variety of pathogens. As IFN-! induced chemokines were found to be 
responsible for NK cell recruitment at 2 and 3 dpi following CPXV infection, we 
measured cytokine protein levels in the draining LN by cytometric bead array. We found 
that following infection with VV, IFN-! was produced at constant levels between 1 and 3 
dpi in the draining LN and diminished between 3 and 6 dpi (Figure 33A). In contrast, 
CPXV did not stimulate production of IFN-! to the same extent as VV until 3 dpi. 
However, CPXV induced higher levels of IFN-! than VV at 6 dpi. IFN-! was reduced by 
9 dpi infection for both viruses and only following CPXV infection did we see minimal 
levels of IFN-! in the draining LN at 12 dpi. These data indicate that infection with VV 
induced a lower IFN-! response at early times following infection that contracted more 
quickly, coinciding with earlier resolution of VV titers in the draining LN. Meanwhile, 
CPXV induced a greater but delayed IFN-! response that was sustained longer and also 
corresponded with resolution of CPXV titers. 
 Following CPXV and VV infection, cytokine production closely correlated with 
the course of infection by either virus. Levels of IL-6, an inflammatory cytokine (149), 
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were similar following infection with either virus at 1 dpi, but differed at subsequent time 
points (Figure 33B, 33C). Levels of IL-6 increased following CPXV infection beginning 
at 2 dpi and peaking between 6 and 9 dpi. In contrast, following VV infection, levels of 
IL-6 remained fairly constant at all time points observed. CPXV in vivo infection induces 
of high levels of IL-10, an anti-inflammatory cytokine (39, 150). Following CPXV 
footpad infection, we observed sustained high levels of IL-10 through 6 dpi. In 
comparison, IL-10 levels following VV were lower at most time points observed, peaking 
at 1 dpi and not detected at 6 dpi. Protein production of MCP-1, otherwise known as 
CCL2, was also measured following infection with CPXV and VV. VV induced high 
CCL2 protein levels at 1 through 6 dpi while CCL2 protein levels were minimal 
following CPXV infections at these times (Figure 33D). Detection of high levels of 
CCL2 did not occur until 9 dpi following CPXV, a time point where CCL2 production 
was declining following VV infection. Taken together, these data suggest that infection 
with CPXV leads to expression of anti-inflammatory cytokines at early times following 
infection, lending further evidence in support of our hypothesis that CPXV more 
completely inhibits the immune response than VV. 
 
Activation of NK Cells is Incomplete Following CPXV Infection 
 The lack of IFN-! production by NK cells suggested that CPXV subverted NK 
cell function. Seemingly in contrast to these findings, we observed an increased viral 
burden in the draining LN in the absence of NK cells, suggesting anti-viral NK cell 
functionality in spite of IFN-! inhibition. We therefore examined whether recruited NK 
cells were activated following infection with CPXV. Examining the surface expression of 
several activation markers, we observed that NK cells isolated from the draining LN had 
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little to no expression of CD69 or CD25 (Figure 34). When examining NK cells isolated 
from the draining LN following VV infection, we observed differential expression of 
surface activation markers. At 1 dpi, CD69 was up-regulated but surface expression 
decreased over time while the inverse was observed for CD25 (Figure 34). These results 
suggested CPXV infection inhibited the activation of NK cells in the draining LN.  
Despite this lower expression of activation markers on NK cells following CPXV, 
systemic depletion of NK cells resulted in increased viral burden. In order to measure NK 
cell function, we examined the induction of granzyme B, an effector molecule in targeted 
cell lysis. In contrast to IFN-! production, NK cells isolated from the draining LN 
following both CPXV and VV infection produced higher levels of granzyme B than NK 
cells isolated from the non-draining LN when examined by flow cytometry (Figure 35). 
These data suggest that since NK cells produced granzyme B, resistance to CPXV 
infection may be mediated through cell lysis.  
 
NK cell Production of IFN-! is Inhibited by CPXV Infection 
We had several hypotheses regarding the differential ability of NK cells to 
produce IFN-! following CPXV or VV infection. The first hypothesis was that VV but 
not CPXV encoded a molecule that was recognized by an activating NK cell receptor, 
akin to m157 mediated activation following MCMV infection (57). Alternately, it was 
also possible that CPXV, having a larger genome than VV and therefore a greater number 
of potentially inhibitory ORFs, contained one or more unique ORFs that inhibited IFN-! 
production by NK cells. Additionally, neither of these hypotheses is mutually exclusive, 
and it was possible that VV produced an activating molecule and CPXV produced an 
inhibitory molecule.  
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To determine if CPXV was inhibiting IFN-! production by NK cells, we 
employed a co-infection model where C57BL/6 mice were injected with either CPXV or 
VV or a mixture of CPXV and VV at a 1:1 ratio. NK cells isolated from the draining LNs 
of co-infected mice did not produce IFN-!, similar to following CPXV infection (Figure 
36A, 36B). These data indicated that NK cell production of IFN-! was being inhibited by 
CPXV infection. To ensure that VV was replicating following co-infection, we used 
CPXV&203-GFP, where GFP has been inserted in the place of CPXV203. Following co-
infection, LNs were titered and plaques that expressed GFP, indicating CPXV replication, 
were counted prior to fixing and staining all plaques on the monolayer allowing 
differentiation between CPXV and VV plaques. At early time points, we observed that 
most plaques were GFP positive, indicating mostly CPXV replication (Figure 36C). 
However, 2 and 3 dpi, we observed plaques that did not express GFP indicating active 
VV replication at later times following co-infection. These data indicate that NK cells 
production of IFN-! is actively inhibited by CPXV infection, even during co-infection 
with VV. 
Next we examined the effect of varying the co-infection ratio to determine 
whether CPXV mediated inhibition of IFN-! production by NK cells could be overcome. 
When the amount of CPXV in the co-infection was lowered, there was an intermediate 
restoration of IFN-! production by recruited NK cells (Figure 37A, 37B). However, when 
the amount of CPXV was maintained at the normal dose and the dose of VV was 
increased, recruited NK cells were not capable of producing IFN-! (Figure 37A, 37B). 
These data suggest that CPXV is producing an inhibitory molecule that at 1.5x106 
pfu/mouse is sufficient to inhibit NK cell production of IFN-!, even in the presence of 
overwhelming VV infection. However, since IFN-! production was less inhibited when 
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using a decreased dose of CPXV during the co-infection, it appears that the putative 
CPXV inhibitory molecule can be titrated. As these data suggested that CPXV inhibition 
could be overcome in vivo, we attempted to stimulate NK cells ex vivo with PMA and 
ionomycin. Treatment with this strong stimulus resulted in production of IFN-! by NK 
cells (Figure 37C). These data indicated that CPXV inhibition can be overcome both in 
vivo by limiting the CPXV infectious dose in a co-infection model and ex vivo with a 
strong stimulus. 
 
Inhibition of IFN-! Production in NK Cells is Complex and Multifactorial 
Next, we performed genomic comparisons between CPXV Brighton Red, ECTV 
Moscow, and VV Western Reserve to identify likely candidate ORFs in CPXV which 
might be responsible for the inhibition of IFN-! production by NK cells. Since footpad 
infection with VV and ECTV induces the recruitment of IFN-! producing NK cells (80, 
81), we chose to exclude CPXV ORFs with homologues in VV or ECTV. Based on a 
nucleotide sequence identity threshold of 80%, we determined that there were 36 unique 
CPXV specific ORFs (Table 2). The identification of CPXV012, CPXV018 and 
CPXV203 in our screen, which have previously been demonstrated to be unique CPXV 
ORFs (29, 30, 85) supported the validity of our screen. 
To rule out ORFs not involved in inhibition of IFN-! by NK cells, we first tested 
viruses deficient for ORFs that had previously been implicated in the down-regulation of 
MHC class I or could bind in vitro with high affinity to the NK activating receptor, 
NKG2D. We found that infection with CPXV&012, CPXV&018, and CPXV&203, 
induced recruitment of NK cells to draining LNs in numbers equivalent to wild-type 
CPXV infection (Figure 38A, 38C, 38E). However, these NK cells still failed to produce 
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IFN-!, indicating that these ORFs were not responsible for the inhibition of NK cells 
(Figure 38B, 38D, 38F).  
Given the large number of CPXV specific ORFs identified in our screen, it 
seemed impractical to generate single mutant deletion viruses for all 36 ORFs and 
systematically examine them for an IFN-! inhibition phenotype. Instead, we employed 
large deletion mutants generated by a collaborator to screen many ORFs at the same time. 
One of these mutants, A587 contains two deletions, one within each terminal region of 
the CPXV genome. ORFs 3-9 and 222-227 are missing from the A587 mutant and 7 of 
the CPXV unique ORFs fall within these deletions including ORF 3, 7, 8, 9, 222, 223, 
and 224. When the A587 mutant was used to infect mice, we found similar recruitment of 
NK cells to the draining LN (Figure 39A) but no IFN-! producing NK cells (Figure 39B). 
Therefore the inhibition of NK production of IFN-! was unchanged and we discounted 
those 7 predicted ORFs.  
 We next examined the A518 mutant, which has one large deletion of ORFs 11-36, 
including 7 unique to CPXV which were identified in our genomic screen: 12, 13, 17, 18 
19, 20 and 31f. Again, recruitment of NK cells to the draining LN was comparable using 
the A518 mutant to recruitment following either CPXV or VV (Figure 40A). When we 
infected using this virus, we found a partial restoration of IFN-! production (Figure 40B). 
The expression of CD69 was also observed at later time points after infection and 
appeared to correlate with the induction of IFN-! expression (Figure 40C). In contrast, 
expression of CD25 did not appear to correlate with IFN-! expression following CPXV 
and A518 mutant infection (Figure 40C). Given the partial restoration of IFN-! and CD69 
expression, we postulated that the inhibitory ORF lay within this deletion. 
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To determine whether a particular ORF was responsible for the lack of IFN-! 
inhibition in the A518 mutant, we used two viruses with deletions within the A518 
deleted region: one lacking ORFs 18-21 and another lacking ORFs 22-36. While both of 
these viruses recruited NK cells similarly to wild-type CPXV (Figure 41A), they also 
both recruited NK cells that produced intermediate IFN-! levels similar to the A518 
recruited NK cells (Figure 41B). These data suggest that CPXV inhibition of IFN-! 
production by NK cells was the product of at least two ORFs in the 11-36 region, making 
inhibition multifactorial. 
 
Discussion 
Here we demonstrate that CPXV recruited NK cells were not fully mature, as 
demonstrated by decreased expression of surface maturation molecules and the inability 
to produce IFN-!. CPXV recruited NK cells retain the ability to produce granzyme B and 
limit viral replication in the draining LN, and are therefore still functional despite 
incomplete maturation. Our data indicate that incomplete NK cell maturation is the 
product of active inhibition by CPXV. This inhibition is complex and multifactorial since 
it is partially abrogated during infection with CPXV mutants that contain large genomic 
deletions. 
NK cells have both the capacity to directly lyse target cells and to induce 
cytokines which shape the adaptive immune response. Following CPXV infection, NK 
cells kill infected cells through direct lysis mediated through granzyme B, but are 
inhibited for IFN-! production. One hypothesis which may explain this phenotype is that 
CPXV can inhibit only one of multiple activation signals that are required to stimulate 
different NK cell functions (151). Supporting this hypothesis, NK cells can express small 
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amounts of Klrg1 and normal granzyme B following CPXV infection. CD69 and IFN-! 
are most highly expressed at early times after infection with VV, and both 
correspondingly decrease as the infection progresses. In either the A518 mutant or the co-
infection model where a partial restoration of IFN-! production was observed, a slight 
increase in CD69 is also observed. These data suggest that the same signal may be 
responsible for CD69 expression and IFN-! induction while induction of granzyme B 
may occur following an alternate signal. Additionally, when examining expression of 
CD25, we observed that it does not appear to be linked to either IFN-! or granzyme B 
expression, suggesting yet another signal might be important for NK cell survival. NK 
cells can respond to a variety of signals including type I IFNs, other pro-inflammatory 
cytokines and direct receptor ligation. Therefore it is possible that integration of multiple 
disparate signals result in different functionality of NK cells. 
There are several alternate hypotheses that could explain this NK cell activation 
phenotype. It is also possible that NK cell stimulation following CPXV infection is 
interrupted and the phenotype results from partial activation by an immediate early or 
early CPXV ORF(s) before inhibition occurs. Additionally, NK cells can be directly 
infected by VV(152, 153), so it is possible they may also be infected by CPXV, limiting 
their activation. At this time, we have not examined CPXV tropism, but direct infection 
of NK cells by CPXV is an intriguing idea. Finally, incomplete activation of NK cells 
could result from a combination of any of these hypotheses. 
When examining cytokine protein expression by multiplex analysis, we found a 
close correspondence between CPXV or VV infection and cytokine induction. Following 
VV infection, there was induction of both IL-6 and IFN-!, both pro-inflammatory 
cytokines that may stimulate more rapid recruitment of inflammatory lymphocytes and 
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therefore early resolution of VV titers in the draining LN. In contrast, CPXV induced 
expression of these inflammatory molecules is delayed. Instead CPXV infection 
increased early expression of IL-10, which is known to be inhibitory towards maturation 
of DCs and macrophages and inhibit function of T and NK cells (150, 154). These 
cytokine expression profiles indicate a more inhibitory nature of CPXV infection in the 
draining LN. 
Following CPXV infection IFN-! protein expression was observed in the draining 
LN. Since we know that recruited NK cells are not responsible for production of this 
IFN-!, another cell must be the source of this cytokine. The early expression of IFN-! 
protein suggests that another innate lymphocyte may be responsible for its production. 
Several innate lymphocytes have been implicated in very early production of IFN-! 
including NKT cells and an innate CD8+ T cell population (131, 155). At this time, these 
populations have not been examined in the context of our CPXV footpad infection. IFN-! 
production continues to increase in the draining LN following CPXV infection, peaking 
at 6 dpi, when adaptive CD8+ T cells could be responsible for its production. While 
CPXV, like all orthopoxviruses, encodes an IFN-! binding protein, this protein has been 
shown to be unable to bind murine IFN-! (156). Thus it is likely that the induction of 
IFN-! helps control CPXV infection in the draining LN. 
The co-infection experiments indicate that CPXV produces an inhibitory 
molecule that dominates any potential VV derived activating molecule. Since co-
infection of single cells is likely to be rare following injection with both CPXV and VV, 
we speculated that the inhibitory molecule was either a surface expressed molecule or 
secreted. If the inhibitory molecule was intracellular, then the cells infected with only VV 
during co-infection would be expected to stimulate IFN-! production by recruited NK 
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cells and intermediate production of IFN-! would be observed. However, the inhibition of 
IFN-! was absolute at all time points observed following co-infection supporting our 
hypothesis that the inhibitory molecule is surface expressed or secreted. 
In attempts to address this hypothesis of extracellular inhibition, we varied the 
ratio of CPXV and VV used during co-infection experiments. These experiments 
indicated that the amount of CPXV present was the limiting factor for inactivation of NK 
cells, again confirmed the dominance of the inhibitory molecule(s). Inhibitory molecules 
are often dominant to activating molecules, examples of which can be found within NK 
cell receptor signaling. NK cell inhibitory receptors that sense MHC class I on potential 
targets cells strongly inhibit activation of NK cells and viruses have evolved to exploit 
this interaction. They do so employing mechanisms including MHC class I mimicry and 
stabilization of Qa-I/HLA-E to signal inhibitory NKG2/CD94 receptors (157-160). Thus 
the strong inhibition of NK cell IFN-! production by CPXV could be overpowering any 
potential ORF encoded by VV and future studies must be performed to determine if such 
an activating ORF exists. 
Our attempt to identify the inhibitory ORF expressed by CPXV resulted in 
discovery of several mutants with intermediate IFN-! production, including the the A518 
mutant, CPXV&18-21 and CPXV&22-36. These findings lead to several potential 
hypotheses. First, it could be that there are multiple ORFs responsible for inhibition of 
IFN-! production, located in this region that could be NK specific. Another possibility is 
that CPXV lacking the inhibitory ORF is not capable of inducing IFN-! production to the 
levels that VV does. Experiments designed to test both of these hypotheses will be 
complicated by numerous non-NK specific inhibitory proteins encoded within the 
terminal regions of the CPXV genome, including multiple cytokine-binding proteins. 
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These data suggest that inhibition of IFN-! is multifactorial and will be difficult to dissect 
using single deletion analysis. 
Here we have examined the activation of NK cells following CPXV footpad 
infection. Surprisingly, given increased viral burdens in systemically NK cell depleted 
mice, NK cells recruited to the draining LN did not produce IFN-! or up-regulate 
activation markers during CPXV infection. Control of viral replication may therefore 
involve granzyme B mediated target cell lysis, as expression of granzyme B remained 
unaffected following CPXV infection. Attempts to identify the CPXV ORFs responsible 
for NK cell inhibition have only underscored the complex, multifactorial nature of NK 
cell function, especially in the context of viral infection. 
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Figure 31: CPXV infection inhibited production of IFN-!  by NK cell recruited to the 
draining LN. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms of CPXV or VV 
or 8.5x104 pfu/ms MCMV and at indicated times, cells from the draining and non-
draining LN were isolated and stained. Following extracellular staining, cells were fixed, 
permeablized and intracellularly stained for IFN-!. Total IFN-! producing NK cells 
(NK1.1+CD3-CD19-IFN-!+) cells following (A) CPXV, VV or (B) MCMV infection are 
graphed. (A) The graph depict average of n=6 independent experiments (18 hpi), n=14 
independent experiments (1 dpi), n=3 independent experiments (36hpi), n=8 independent 
experiments (2 & 3 dpi), and n=2 independent experiments (6 & 9 dpi).  
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Figure 32: VV infection but not CPXV infection stimulated NK production of IFN-! 
in a dose dependent manner. 
Age and sex matched C57BL/6 mice were infected with 3.75 x 103 pfu/mouse to 3.75 x 
106 pfu/mouse of (A, C) CPXV or (B, D) VV. At indicated time points, cells from the 
draining and non-draining LN were isolated and stained. Following extracellular staining, 
cells were fixed, permeablized and intracellularly stained for IFN-!. (A, B) Percent and 
(C, D) total IFN-! producing NK Cells (NK1.1+CD3-CD19-IFN-!+) cells following (A, 
C) CPXV and (B, D) VV infection are graphed.  
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Figure 33: Kinetic analysis of cytokine expression in the draining LN following 
CPXV and VV infection. 
Age and sex matched C57BL/6 mice were infected as before with CPXV or VV and at 
indicated times, LNs were isolated and homogenized by bead beating in RPMI. Cytokine 
production was measured using the mouse inflammation cytometric bead array. (A) IFN-
!, (B) IL-6, (C) IL-10 and (D) CCL2 (MCP-1) expression are graphed over time. The 
graph depicts the average of n=4 to 5 independently infected mice (1, 2, 3, 6, and 9 dpi) 
and n= 2 (CPXV) to 5 (VV) independently infected mice. 
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Figure 34: Kinetic analysis of NK cell expression of surface activation molecules 
following CPXV or VV infection. 
Age and sex matched C57BL/6 mice were infected as before with CPXV or VV and at 
indicate times, lymphocytes from the draining and non-draining LN were isolated and 
stained. Following identification of NK cells (NK1.1+CD3-CD19-), surface expression of 
CD69 and CD25 was determined. A representative result of 3 independent experiments is 
depicted. 
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Figure 35: NK cells produce granzyme B following CPXV and VV infection. 
Age and sex matched C57BL/6 mice were infected as before and at indicated times, 
lymphocytes from the draining and non-draining LN were isolated and stained. Following 
extracellular staining, cells were fixed, permeablized and intracellularly stained for IFN-! 
and granzyme B. Following identification of NK cells (NK1.1+CD3-CD19-), IFN-! and 
granzyme production was assessed. A representative dot plot from 10 independent 
experiments is shown. 
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Figure 36: NK cells do not produce IFN-! following co-infection with CPXV and 
VV. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms CPXV, VV or a 
1:1 mixture of CPXV and VV. At indicated times, lymphocytes from the draining and 
non-draining LN were isolated and stained. Following extracellular staining, cells were 
fixed, permeablized and intracellularly stained for IFN-!. (A) Percent and (B) total IFN-! 
producing NK cells (NK1.1+CD3-CD19-IFN-!+) for 4 independent experiments are 
depicted. (C) C57BL/6 mice were injected with 1.5x106 pfu/ms CPXV&203-GFP, VV or 
a 1:1 mixture of CPXV&203-GFP and draining LNs were titered on CV-1 monolayers. 
GFP-expressing plaques were counted prior to crystal violet staining. Data represent the 
average of 1 mouse from 2 independent experiments. 
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Figure 37: Inhibition of NK cell IFN-! production can be overcome. 
Age and sex matched C57BL/6 mice were infected with CPXV, VV or with 0.1:1, 1:1 or 
1:10 mixtures of CPXV and VV. Lymphocytes from the draining and non-draining LN 
were isolated and stained 1 dpi. Following extracellular staining, cells were fixed, 
permeablized and intracellularly stained for IFN-!. (A) Percent and (B) total IFN-! 
producing NK cells (NK1.1+CD3-CD19-IFN-!+) are graphed. The graph depicts the 
average of data from 2 to 4 independent experiments. (C) C57BL/6 mice were infected 
with CPXV and lymphocytes were isolated at 1, 2 or 3 dpi and stimulated with 
PMA/ionomycin for 8 hours. Following identification of NK cells (NK1.1+CD3-CD19-), 
IFN-! expression was assessed. A representative result of 4 independent experiments is 
depicted. 
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Table 2: ORFs found in CPXV but not ECTV or VV. 
This table lists ORFs determined by comparing the genomes of CPXV-Brighton Red, 
VV-Western Reserve, and ECTV-moscow strains using 80% identity threshold. The 
screen identified 36 ORFs that were unique to CPXV-Brighton Red. 
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Predicted Protein Information CPXV ORF 
1 or 2 predicted membrane spanning sequences 1, 3, 7, 47, 58, 63, 119a, 130, 160, 170, 192, 
214, 224, 229 
Ankryin domain 8, 17, 19, 220, 223 
Secretory signal peptide 18, 170 
Homologous to CMPX TLR inhibitor 9, 222 
MHC I downregulation 12, 203 
Galactose oxidase / transcriptional repression 13 
Viral sensitivity to "-amanitin 10 
no information 2, 31f, 51a, 78a, 96, 116, 152a, 216, 228 
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Figure 38: The inhibition of IFN-! production by NK cells is unaffected in the 
absence of  CPXV012, CPXV018 and CPXV203. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type 
CPXV, VV or (A) CPXV&012, (B) CPXV&018 or (C) CPXV&203. Lymphocytes from 
the draining and non-draining LN were isolated and stained 1 dpi. Following extracellular 
staining, cells were fixed, permeablized and intracellularly stained for IFN-!. NK cells 
(NK1.1+CD3-CD19-) were identified and IFN-! expression was assessed. Both percent 
and total IFN-! producing cells are depicted. 
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Figure 39: The A587 mutant inhibits NK cell IFN-! production. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type 
CPXV, VV or A587. Lymphocytes from the draining and non-draining LN were isolated 
and stained 1 dpi. Following extracellular staining, cells were fixed, permeablized and 
intracellularly stained for IFN-!. NK cells (NK1.1+CD3-CD19-) were identified and IFN-
! expression was assessed. (A) Percent and (B) total IFN-! producing NK cells 
(NK1.1+CD3-CD19-IFN-!+) are graphed. 
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Figure 40: NK cells activation is partially restored following infection with the A518 
mutant. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type 
CPXV, VV or A518. Lymphocytes from the draining and non-draining LN were isolated 
and stained 1 dpi. Following extracellular staining, cells were fixed, permeablized and 
intracellularly stained for IFN-!. (A) Percent and (B) total IFN-! producing NK cells 
(NK1.1+CD3-CD19-IFN-!+) are graphed. Data from 5 independent experiments are 
depicted. (C) Following identification of NK cells (NK1.1+CD3-CD19-), CD69 and CD25 
surface expression was assessed. A representative result of 2 independent experiments is 
depicted. 
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Figure 41: CPXV inhibition of NK cell IFN-! production is control by multiple 
ORFs. 
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type 
CPXV, VV, A518, CPXV&018-021, or CPXV&022-036. Lymphocytes from the draining 
and non-draining LN were isolated and stained 1 dpi. Following extracellular staining, 
cells were fixed, permeablized and intracellularly stained for IFN-!. (A) Percent and (B) 
total IFN-! producing NK cells (NK1.1+CD3-CD19-IFN-!+) are graphed. The graphs 
depict the average of data from 3 to 5 independent experiments. 
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Cowpox Footpad Infection Provides a Relevant Model for Zoonotic Infection  
Orthopoxviruses cause zoonotic infection and several have been well 
characterized in existing laboratory models. Most investigation of orthopoxvirus 
pathogenesis employ intravenous or intranasal infection (30, 39, 90). Intravenous 
infection simulates systemic infection while intranasal infection simulates aerosolized 
infection and models inoculation following natural smallpox infection or predicted 
dissemination during a bioterrorist event. However the literature demonstrate that most 
CPXV infections occur through contact-mediated spread within the host reservoir and to 
zoonotic hosts (6, 8, 91). Previous investigations of CPXV infection in a footpad mouse 
model have been limited in scope and did not examine the host response (90, 93). We 
have developed a footpad model of CPXV infection in mice and have demonstrated 
establishment of infection at the site of inoculation and in the draining LN, from where 
secondary dissemination originates at later times. This footpad model more closely 
parallels infection with orthopoxviruses such as zoonotic CPXV infection of humans, 
where viral replication has been observed only at the site of infection (9). In zoonotic 
CPXV infections, lymphadenopathy results from recruitment of lymphocytes to draining 
LNs. In mice, CPXV footpad inoculation stimulated recruitment of many lymphocytes to 
the draining LN, including NK cells, which highlights the relevance of our footpad model 
for the study of in vivo CPXV infection. We have shown that our model can provide a 
unique opportunity to study immune responses following inoculation with CPXV via its 
natural route of infection. 
 
NK Cells are Required for Resistance to but Not Survival of CPXV Footpad 
Infection 
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Immediately following infection, innate lymphocytes are recruited to the site of 
infection and the draining LN.  Here they stimulate an inflammatory response and 
directly control infection while an adaptive immune response is primed. One innate 
lymphocyte that is important at early times following infection is the NK cell, which 
produces cytokines and lyses infected cells. Under homeostatic conditions, murine NK 
cells are a rare LN population (74), so observation of rapid and robust expansion of NK 
cell numbers in the draining LN following CPXV infection suggested that they were 
important for resistance to this pathogen.  
Since CPXV encodes many unique inhibitory proteins, we hypothesized that NK 
cell function might be inhibited following CPXV infection. However, following systemic 
NK cell depletion, CPXV replication in the draining LN was significantly increased, 
indicating NK cells were functional following CPXV infection. It has been demonstrated 
that splenic titers of ECTV are increased following footpad inoculation in the absence of 
NK cells (81). Following inoculation with CPXV in the footpad, we observed early 
spread to the lungs and the spleen in the absence of NK cells. These data demonstrate that 
NK cells are important for limiting viral replication and spread following both ECTV and 
CPXV infection. Therefore, we concluded that the unique inhibitory proteins of CPXV 
do not completely neutralize NK cell control of replication and dissemination. 
We examined the importance of NK cell control of viral replication and spread by 
observing survival following CPXV infection in the NK cell depleted mice. In contrast to 
previous studies using ECTV and VV which demonstrate a requirement of NK cells for 
survival (80-82), depletion of NK cells prior to CPXV infection did not lead to increased 
mortality. These novel findings indicate that there are differential requirements for NK 
cells following orthopoxviral infections. Another possibility is that since intravenous 
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inoculation was used to examine the requirement of NK cells for survival following VV 
infection, it is possible that following footpad inoculation in the absence of NK cells, 
lethality may not occur. It is also possible that we did not observe CPXV lethality 
because the infectious dose of CPXV was too low. Dose-response experiments could be 
performed examining the NK cell requirement for survival following larger infectious 
doses of CPXV in the footpad model.  However, high-dose inoculation following contact-
mediated spread within the host reservoir or to zoonotic hosts seems unlikely. We have 
concluded that NK cells are important for limiting viral replication and dissemination 
following CPXV infection but are not essential for survival at the dose examined. 
 
Mechanisms of NK Cell Recruitment 
Expansion of the NK cell population in the draining LN following CPXV 
infection resulted from chemokine-mediated recruitment rather than in situ proliferation 
of relatively rare resident cells. The role of chemokine receptor-mediated trafficking of 
murine NK cells to the site of infection has been studied in the context of several 
pathogens, but no commonly required chemokine receptor has been identified (64, 75, 76, 
108, 140). NK cells are recruited to sites of inflammation despite expression of a variety 
of inflammatory chemokines in the context of different pathogens. Therefore NK cells 
must express an array of inflammatory chemokine receptors to mediate this response 
(65). Additionally, expression of multiple chemokine receptors adds a protective level of 
redundancy for host resistance to infection.  
Previous studies have not identified specific chemokine receptors that mediate 
NK cell recruitment following orthopoxvirus infection. Here we demonstrated an 
intrinsic requirement for CXCR3 expression on the NK cell which mediates recruitment 
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to the draining LN following CPXV infection. Meanwhile, CCR2 and CCR5, which have 
been shown to be required following infection with MCMV, HSV-2, Aspergillus 
fumigatus and Toxoplasma gondi (64, 75, 76, 108), were not found to be individually 
necessary to mediate NK cell recruitment. While this work was in progress, it was 
demonstrated that MVA, a highly attenuated orthopoxvirus, stimulates recruitment of NK 
cells to draining LNs in a CXCR3-dependent and CCR5-independent manner (140), 
confirming our results. Additionally, CXCR3 has been demonstrated to be responsible for 
NK cell recruitment several inflammatory but non-infectious responses and for re-
localization of NK cells from the red pulp to the T cell zone in the spleen following 
MCMV infection (105-107, 109). CXCR3 receptor-mediated NK cell recruitment is 
perhaps unsurprising, since inflammation often results in the production of IFN-! and 
expression of the chemokine ligands for CXCR3 is induced by this cytokine (104). Since 
a role for CXCR3 has not been examined in response to other pathogens, it may indeed 
be a commonly required chemokine receptor for NK cell trafficking. Expression of 
CXCR3 has been suggested as a marker of mature, cytotoxic NK cells (161), supporting 
the hypothesis that CXCR3 is ubiquitously expressed on many NK cells. Therefore, 
CXCR3 may be a commonly important receptor for recruitment of NK cells to sites of 
inflammation and infection. 
We also determined that there was a requirement for IFN-! following CPXV 
infection. As discussed above, IFN-! is important for induction of inflammatory 
chemokines including CXCR3. However, in the absence of CXCR3, NK cell recruitment 
was decreased but not abolished. This indicated that IFN-! was also inducing other 
inflammatory mediators, possibly other inflammatory chemokines. Since IFN-! is 
upstream of multiple processes, only one of which is recruitment of NK cells, its role in 
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mediating CXCR3-independent NK cell recruitment following CPXV infection is likely 
to be complex and difficult to dissect. 
 
A Role for DC-Mediated NK Cell Recruitment is Difficult to Ascertain 
It has previously been demonstrated that footpad injection of LPS-matured DCs 
results in the trafficking of DCs from the periphery to the draining LN, where they 
stimulate recruitment of NK cells that produce IFN-! to prime a TH1 response (107). This 
interaction, in combination with many documented interplays between NK cells and DCs 
(44, 45, 53, 117), raises the possibility that DCs mediate recruitment of NK cells in 
response to CPXV infection. The migration of DCs from the periphery to the draining LN 
is dependent on the up-regulation of CCR7 and does not occur in mice deficient for 
CCR7 (162). We did not observe NK cell recruitment to the draining LN in CCR7-
deficient mice, supporting the hypothesis that DCs recruit NK cells to draining LNs. 
However, the LN architecture is disorganized in CCR7-deficient mice which likely leads 
to defective trafficking of many lymphocytes, complicating interpretation of this 
experiment (99). To further investigate the hypothesis that DCs recruit NK cells, we 
examined the recruitment of migratory DCs from the periphery to the draining LN 
following CPXV infection. Surprisingly, given the commonly accepted paradigm of 
pathogen recognition stimulating migration of DCs from the periphery to the draining 
LN, we observed comparable populations of migratory DCs in non-draining and draining 
LNs. These data suggested that following CPXV footpad inoculation, DCs were not 
migrating from the periphery at a greater rate or in greater numbers than under 
homeostatic conditions. Additionally, while CD11c-DTR diphtheria toxin-depleted mice 
showed major defects in NK cell recruitment, macrophages and other cells ectopically 
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express CD11c and are depleted, confounding interpretation of these results (133, 138). 
Attempts to restore DC populations in deficient systems did not result in increased NK 
cell trafficking following CPXV infection. While data from several different experiments 
suggest that DCs may play a role in recruitment of NK cells to the draining LN following 
CPXV infection, we have been unable to establish a system that can conclusively identify 
a role in NK cell recruitment. These data raise the possibility that DCs may be important, 
but not sufficient for NK cell recruitment in this system.  
 
A Novel Macrophage and NK Cell Interaction 
SCS macrophages can phagocytose and detect free viral particles arriving from 
the periphery through the lymphatic system (94, 129, 130). Following diphtheria toxin-
mediated depletion of CD11c-DTR transgenic mice, SCS macrophages were depleted, 
raising the possibility that they may be required for NK cell recruitment to the draining 
LN following CPXV infection (133). To test this hypothesis, we infected macrophage-
depleted mice with CPXV and examined NK cell recruitment to the draining LN. Mice 
that lacked macrophages in the draining LN exhibited no NK cell recruitment indicating a 
novel interaction between macrophages and NK cells. During our subsequent studies, 
several reports were published that also observed NK cell interactions with CD169+ SCS 
macrophages and a requirement of macrophages for NK cell recruitment (131, 139, 140). 
Our findings, in combination with these recently reported results, indicate a novel 
interaction between macrophages and NK cells.  
Macrophages can detect infection and induce inflammation, including through 
production of IFN-!-induced CXCL9 and CXCL10 (134, 135). We therefore 
hypothesized that macrophages mediated NK cell recruitment to the draining LN 
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following CPXV infection in a CXCR3-dependent manner. However, depletion of 
macrophages and subsequent CPXV infection induced comparable levels of Cxcl9 and 
Cxcl10 expression as in non-depleted mice. These data indicate that macrophages recruit 
NK cells in a CXCR3-independent manner. However, the mechanism of macrophage-
mediated NK cell recruitment is currently unknown. One possibility to explain 
macrophage-mediated recruitment is that SCS macrophages are the preferentially 
infected cell in the draining LN following CPXV infection, and removal of macrophages 
results in diminished host recognition and therefore decreased inflammation and 
lymphocyte recruitment. Another possibility is that while Cxcl9 and Cxcl10 expression 
was unaffected, many viruses stimulate type I IFN production, which can lead to 
expression of different chemokines such as CCL3 (77). We observed increased 
expression of Ccl3 transcripts following both CPXV and VV infection, so it is possible 
that macrophages induce type I IFN and mediate recruitment of NK cells through 
alternate inflammatory chemokines. These data indicate that there are two, non-
overlapping pathways to recruit NK cells to the draining LN following infection, 
emphasizing the importance of the expansion of the NK cell population in the draining 
LN in response to viral infection.  
 
Inappropriate Association of NK Cell Resistance and NK Cell Recruitment 
NK cell-mediated resistance to ECTV infection has been inferred by the 
expansion of IFN-! and granzyme B producing NK cells in the draining LN (80, 81). 
However, control of ECTV in the draining LN in the presence or absence of NK cells has 
not been described in the literature. Here we have demonstrated that recruitment of NK 
cells was unnecessary for control of viral replication in the draining LN or spread to the 
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spleen and lungs. While NK cells were essential for control of viral burden in these 
organs, their specific recruitment was not necessary and rare NK cells present in the 
draining LN controlled viral replication in the absence of NK cell recruitment. While this 
could be a function of CPXV infection in comparison to ECTV infection, it does not 
appear that expansion of the population and control of infection can be linked. 
 
Incomplete NK Cell Maturation Despite Cytotoxic Function 
When examining the maturation phenotype of NK cells isolated from the draining 
LN following CPXV infection, we observed that NK cells did not produce IFN-! or up-
regulate some surface activation markers. This inhibition was CPXV specific and could 
be overcome ex vivo by stimulating with PMA and ionomycin or in vivo by limiting the 
infectious dose of CPXV during a co-infection with VV. Although CPXV inhibited NK 
cell production of IFN-!, systemic depletion of NK cells resulted in increased local and 
systemic viral burden. These data suggest that NK cells are partially activated following 
infection and their function is likely due to production of granzyme B. Since it has been 
demonstrated that stimulation of NK cells by cytokines and through activating receptors 
results in different NK cell functions, CPXV may block one but not all activation signals, 
resulting in this partially activated phenotype. Most infections lead to both NK cell 
cytotoxicity and cytokine production, but it has been reported that following 
Lymphocytic Choriomeningitis (LCMV) infection, NK cells have cytotoxic function but 
do not produce IFN-! due to the lack of IL-12 induction (163). To our knowledge, no IL-
12 binding protein has been identified in CPXV, but it is likely that CPXV has other 
mechanisms to subvert IL-12 production. It is then possible that a lack of IL-12 
production may be a shared mechanism of NK cell inhibition following CPXV and 
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LCMV infection. It is also possible that these systems may share additional stimulatory 
and/or inhibitory signals. Thus determining shared activation and inhibition signals 
during viral infection may help further understanding of differential NK cell activation 
signals.  
CPXV-mediated inhibition of IFN-! was multifactorial, suggesting the 
involvement of both NK cell specific and non-NK cell specific virally encoded inhibitory 
proteins. Partial restoration of IFN-! production by recruited NK cells was observed 
following infection with the A518 mutant, CPXV&018-021 and CPXV&022-36. 
CPXV018 inhibits NKG2D activation in vitro (85), but CPXV&018 did not recruit IFN-! 
producing NK cells to the draining LN, suggesting an additional mechanism of IFN-! 
inhibition. Induction of IFN-! production in NK cells can be stimulated by IL12, IL-15 
and IL-18 and inhibited by IL-10 in the absence of IL-12 (54, 154, 164-166). CPXV 
encodes an IL-18 binding protein and induces sustained high levels of IL-10 which may 
non-specifically contribute to NK cell inhibition (34, 39). VV hemagglutinin expression 
is recognized by NKp30 and NKp46 in HeLa cells, resulting in NK cell inhibition (167-
169). The ability of CPXV hemagglutinin to bind these natural cytotoxicity receptors has 
not been examined, but it is possible that CPXV also mediates NK cell inhibition through 
this mechanism.  The numerous CPXV inhibitory proteins and their individual and 
synergistic effects on the host response clearly confer a strong advantage to CPXV during 
infection of the host, but will also complicate any attempt to discern individual 
contributions of each inhibitory protein to CPXV immune evasion.   
Although NK cells did not produce IFN-! following CPXV infection, increased 
viral burden following systemic NK cell depletion indicated that NK cells were an 
important component of the host response. Additionally, given the number of viral 
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inhibitory proteins that directly or indirectly impact NK cell activation, it must be 
advantageous for CPXV to even partially inhibit NK cell function. It is interesting to 
speculate about the ability of CPXV to infect and disseminate within the host in the 
context of uninhibited NK cell activation. Several experiments could be designed to 
overcome the in vivo inhibition of NK cells. The importance of IL-12 and IL-18 for NK 
cell activation has been demonstrated following ECTV and VV suggesting they might 
also be important following CPXV infection (41, 42). Since inhibition may occur through 
or be modulated by virally encoded cytokine binding proteins, treatment with IL-12 
and/or IL-18 or infection with CPXV which recombinantly expresses either cytokine 
could result in saturation of virally encoded cytokine binding proteins, allowing NK cell 
activation. Another way to restore NK cell functionality might be examine NK cell 
activation following infection with the CPXV&018 mutant. Although our studies have 
demonstrated that lack of CPXV018 does not restore IFN-! production, it is possible that 
CPXV018 may also inhibit cytotoxic NK cell function. Inhibition of NK cell function 
may be essential for establishment CPXV infection and dissemination within the host.  
These proposed experiments may help dissect the reason CPXV encodes many inhibitory 
proteins against NK cell function.  
Aside from cytotoxicity and stimulation of inflammation, NK cell production of 
IFN-! also shapes the TH1 response (107). It is possible that priming of the adaptive 
immune response is delayed following CPXV infection in comparison to VV or ECTV 
infection in the absence of NK cell produced IFN-!. The scope of these studies did not 
include an examination of this process, but systemic depletion of NK cells did result in 
delayed viral clearance in the draining LN and the foot, suggesting a delay in the adaptive 
immune response. Therefore, CPXV inhibition of IFN-! may be beneficial for both 
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suppressing NK lysis of CPXV infected cells and delaying the priming of a TH1 response, 
resulting in prolonged CPXV infection. 
 
Clinical Relevance 
Many studies use members of the orthopoxvirus genus to model smallpox virus 
infection, but symptoms, viral spread and disease course vary greatly between these 
orthopoxviruses. Despite the lack of lethality following CPXV infection in the mouse 
model, footpad infection of mice closely mimics zoonotic infection making it a relevant 
model to study vacciniation and zoonotic infection following a range of non-lethal 
orthopoxvirus infections. Vaccination of patients that are immunocompromised or have 
atopic dermatitis is not advised, but with increasing numbers of emerging and zoonotic 
poxvirus infections, safer vaccine development is crucial. Many strategies have been 
employed to generate new vaccines, including directed deletion of inhibitory proteins. 
Since NK cells are important for limiting early viral replication, inducing inflammation 
and priming the adaptive immune response, removal of virally encoded NK cell specific 
and non-NK cell specific inhibitors from novel candidate vaccine strains is important. 
Conversely, in inflammatory diseases where NK cells are inappropriately activated, 
identification of virally encoded NK cell specific inhibitors may be a useful therapeutic 
treatment. 
 
Concluding Remarks 
 Studies examining the host response to viral infection and viral immune evasion 
provide insight into the complexity of host-pathogen interaction. In these studies, we 
have demonstrated the relevance of studying CPXV in a footpad model of infection to 
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further characterize and understand zoonotic orthopoxvirus infections. We have 
highlighted the importance of NK cells following CPXV infection, studied the 
mechanism of NK cell recruitment in the context of natural infection and the complicated 
and multifactorial nature of viral inhibition of NK cell function. Further investigation will 
help illuminate and dissect these intricate host-pathogen interactions. 
 177 
REFERENCES 
 
1. Fenner F (1988) Smallpox and its eradication (The World Health Organization). 
2. Riedel S (2005) Edward Jenner and the history of smallpox and vaccination. 
Proceedings (Baylor University Medical Center) 18:21. 
3. Parker S, Nuara A, Buller RML, Schultz DA (2007) Human monkeypox: an 
emerging zoonotic disease. Future Microbiol 2:17–34. 
4. Ligon BL (2004) Monkeypox: a review of the history and emergence in the 
Western hemisphere. Semin Pediatr Infect Dis 15:280–287. 
5. Jezek Z et al. (1986) Four generations of probable person-to-person transmission 
of human monkeypox. Am J Epidemiol 123:1004–1012. 
6. Campe H et al. (2009) Cowpox virus transmission from pet rats to humans, 
Germany. Emerging Infect Dis 15:777–780. 
7. Wollenberg A et al. (2012) The Munich Outbreak of Cutaneous Cowpox 
Infection: Transmission by Infected Pet Rats. Acta Derm Venerol 92:126–131. 
8. Ninove L et al. (2009) Cowpox virus transmission from pet rats to humans, 
France. Emerging Infect Dis 15:781–784. 
9. Vorou RM, Papavassiliou VG, Pierroutsakos IN (2008) Cowpox virus infection: 
an emerging health threat. Curr Opin Infect Dis 21:153–156. 
10. Chantrey J et al. (1999) Cowpox: reservoir hosts and geographic range. 
Epidemiology and Infection 122:455. 
11. Pelkonen PM et al. (2003) Cowpox with Severe Generalized Eruption, Finland. 
Emerging Infect Dis 9:1458. 
12. Mack TM (1972) Smallpox in Europe, 1950-1971. J Infect Dis 125:161–169. 
13. Kim S-H, Oh M-D (2007) Persistence of cell-mediated immunity to vaccinia 
virus. J Infect Dis 196:805–806. 
14. Amanna IJ, Slifka MK, Crotty S (2006) Immunity and immunological memory 
following smallpox vaccination. Immunol Rev 211:320–337. 
15. Baxby D (1977) The origins of vaccinia virus. J Infect Dis 136:453–455. 
16. R HI, Bowie AG (2005) Evasion of innate immunity by vaccinia virus. 
Parasitology 130:S11. 
17. Moss B (2011) Smallpox vaccines: targets of protective immunity. Immunol Rev 
239:8–26. 
18. Verardi PH, Titong A, Hagen CJ (2012) A vaccinia virus renaissance: New 
vaccine and immunotherapeutic uses after smallpox eradication. Hum Vaccin 
Immunother 8:961–970. 
19. Gomes JAS et al. (2012) Immune Modulation in Primary Vaccinia virus 
Zoonotic Human Infections. Clinical and Developmental Immunology 2012:1–
11. 
20. Carroll DS et al. (2011) Chasing Jenner's Vaccine: Revisiting Cowpox Virus 
Classification. PLoS One 6:e23086. 
21. Bennett M et al. (1997) Cowpox in British voles and mice. J Comp Pathol 
116:35–44. 
22. Upton C, Slack S, Hunter AL, Ehlers A, Roper RL (2003) Poxvirus Orthologous 
Clusters: toward Defining the Minimum Essential Poxvirus Genome. J Virol 
77:7590–7600. 
23. Seet BT et al. (2003) Poxviruses and immune evasion. Annu Rev Immunol 
21:377–423. 
 178 
24. Alzhanova D, Früh K (2010) Modulation of the host immune response by 
cowpox virus. Microbes Infect 12:900–909. 
25. Delaloye J et al. (2009) Innate Immune Sensing of Modified Vaccinia Virus 
Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 
Inflammasome. PLoS Pathog 5:e1000480. 
26. Samuelsson C et al. (2008) Survival of lethal poxvirus infection in mice depends 
on TLR9, and therapeutic vaccination provides protection. The Journal of 
Clinical Investigation 118:1776. 
27. Zhu J, Martinez J, Huang X, Yang Y (2007) Innate immunity against vaccinia 
virus is mediated by TLR2 and requires TLR-independent production of IFN. 
The Journal of Clinical Investigation 109:619–625. 
28. González JM, Esteban M (2010) A poxvirus Bcl-2-like gene family involved in 
regulation of host immune response: sequence similarity and evolutionary 
history. Virol J 7:59. 
29. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM (2007) Cowpox virus 
exploits the endoplasmic reticulum retention pathway to inhibit MHC class I 
transport to the cell surface. Cell Host Microbe 2:306–315. 
30. Byun M et al. (2009) Two mechanistically distinct immune evasion proteins of 
cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 6:422–
432. 
31. Dasgupta A, Hammarlund E, Slifka MK, Früh K (2007) Cowpox virus evades 
CTL recognition and inhibits the intracellular transport of MHC class I 
molecules. J Immunol 178:1654–1661. 
32. Alzhanova D et al. (2009) Cowpox virus inhibits the transporter associated with 
antigen processing to evade T cell recognition. Cell Host Microbe 6:433–445. 
33. Katze MG, He Y, Gale M (2002) Viruses and interferon: A fight for supremacy. 
Nat Rev Immunol 2:675–687. 
34. Reading P, Smith G (2003) Vaccinia virus interleukin-18-binding protein 
promotes virulence by reducing gamma interferon production and natural killer 
and T-cell activity. J Virol 77:9960–9968. 
35. Perdiguero B, Esteban M (2009) The Interferon System and Vaccinia Virus 
Evasion Mechanisms. Journal of Interferon & Cytokine Research 29:581–598. 
36. Mahalingam S, Karupiah G (2000) Modulation of chemokines by poxvirus 
infections. Current Opinion in Immunology 12:409–412. 
37. Vaheri A, Nepomnyashchikh TS, Shchelkunov SN (2010) SECRET domain of 
variola virus CrmB protein can be a member of poxviral type II chemokine-
binding proteins family. BMC Research Notes 3:271. 
38. Alcami A, Lira SA (2010) Modulation of chemokine activity by viruses. Curr 
Opin Immunol 22:482–487. 
39. Spesock AH et al. (2011) Cowpox virus induces interleukin-10 both in vitro and 
in vivo. Virology 417:87–97. 
40. Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA (2009) The 
immunology of smallpox vaccines. Current Opinion in Immunology 21:314–320. 
41. Wang Y, Chaudhri G, Jackson R, Karupiah G (2009) IL-12p40 and IL-18 play 
pivotal roles in orchestrating the cell-mediated immune response to a poxvirus 
infection. J Immunol 183:3324–3331. 
42. Gherardi MM (2003) IL-12 and IL-18 act in synergy to clear vaccinia virus 
infection: involvement of innate and adaptive components of the immune system. 
 179 
Journal of General Virology 84:1961–1972. 
43. Perera LP, Goldman CK, Waldmann TA (2001) Comparative assessment of 
virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in 
immunodeficient mice. Proc Natl Acad Sci USA 98:5146–5151. 
44. Moretta L et al. (2006) Effector and regulatory events during natural killer-
dendritic cell interactions. Immunol Rev 214:219–228. 
45. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA (2004) NK cell 
and DC interactions. Trends Immunol 25:47–52. 
46. Yammani RD et al. (2008) Regulation of maturation and activating potential in 
CD8+ versus CD8" dendritic cells following in vivo infection with vaccinia 
virus. Cell 378:142–150. 
47. Hansen SJ et al. (2011) Cowpox virus inhibits human dendritic cell immune 
function by nonlethal, nonproductive infection. Cell 412:411–425. 
48. Engelmayer J et al. (1999) Vaccinia virus inhibits the maturation of human 
dendritic cells: a novel mechanism of immune evasion. J Immunol 163:6762–
6768. 
49. Rivera R et al. (2007) Murine alveolar macrophages limit replication of vaccinia 
virus. Virology 363:48–58. 
50. Humlová Z, Vokurka M, Esteban M, M#lková Z (2002) Vaccinia virus induces 
apoptosis of infected macrophages. J Gen Virol 83:2821–2832. 
51. Jonsson AH, Yokoyama WM (2009) Natural killer cell tolerance licensing and 
other mechanisms. Adv Immunol 101:27–79. 
52. Yokoyama WM, Plougastel BFM (2003) Immune functions encoded by the 
natural killer gene complex. Nat Rev Immunol 3:304–316. 
53. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA 
(2003) Functional interactions between dendritic cells and NK cells during viral 
infection. Nat Immunol 4:175–181. 
54. Christine A Biron, Khuong B Nguyen, Gary C Pien, Leslie P Cousens, Salazar-
Mather TP (1999) Natural Killer Cells in Antiviral Defense: Function and 
Regulation by Innate Cytokines. Annu Rev Immunol 17:189–220. 
55. Kärre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-
2-deficient lymphoma variants suggests alternative immune defence strategy. 
Nature 319:675–678. 
56. Gasser S, Raulet DH (2006) Activation and self-tolerance of natural killer cells. 
Immunol Rev 214:130–142. 
57. Scalzo AA, Yokoyama WM (2008) Cmv1 and natural killer cell responses to 
murine cytomegalovirus infection. Curr Top Microbiol Immunol 321:101–122. 
58. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HW (2004) Natural Killer 
Cells Utilize both Perforin and Gamma Interferon To Regulate Murine 
Cytomegalovirus Infection in the Spleen and Liver. J Virol 79:661–667. 
59. Fehniger TA et al. (2007) Acquisition of murine NK cell cytotoxicity requires 
the translation of a pre-existing pool of granzyme B and perforin mRNAs. 
Immunity 26:798–811. 
60. Kim S, Yokoyama WM (1998) NK Cell Granule Exocytosis and Cytokine 
Production Inhibited by Ly-49A Engagement. Cellular Immunology 183:106–
112. 
61. Yokoyama WM, Kim S, French AR (2004) The dynamic life of natural killer 
cells. Annu Rev Immunol 22:405–429. 
 180 
62. Arase H, Arase N, Saito T (1996) Interferon gamma production by natural killer 
(NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. The Journal of 
Experimental Medicine 183:2391. 
63. Dorner BG et al. (2004) Coordinate expression of cytokines and chemokines by 
NK cells during murine cytomegalovirus infection. J Immunol 172:3119–3131. 
64. Salazar-Mather TP, Orange JS, Biron CA (1998) Early murine cytomegalovirus 
(MCMV) infection induces liver natural killer (NK) cell inflammation and 
protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-
dependent pathways. J Exp Med 187:1–14. 
65. Moser B, Willimann K (2004) Chemokines: role in inflammation and immune 
surveillance. Ann Rheum Dis 63 Suppl 2:ii84–ii89. 
66. Cyster JG (1999) Chemokines and cell migration in secondary lymphoid organs. 
Science 286:2098–2102. 
67. Müller M, Carter S, Hofer MJ, Campbell IL (2010) Review: The chemokine 
receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in 
neuroimmunity - a tale of conflict and conundrum. Neuropathology and Applied 
Neurobiology 36:368–387. 
68. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP (2005) Monocyte 
chemoattractant protein-1 and CCR2 interactions are required for IFN-
alpha/beta-induced inflammatory responses and antiviral defense in liver. J 
Immunol 174:1549–1556. 
69. Sunny C Yung PMM (2012) Antimicrobial Chemokines. Frontiers in 
Immunology 3. 
70. Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, 
interactions, and antagonism. Annu Rev Immunol 25:787–820. 
71. Deng Q, Barbieri JT (2008) Molecular mechanisms of the cytotoxicity of ADP-
ribosylating toxins. Annu Rev Microbiol 62:271–288. 
72. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. 
71:173–183. 
73. Maghazachi AA (2003) G protein-coupled receptors in natural killer cells. J 
Leukoc Biol 74:16–24. 
74. Grégoire C et al. (2007) The trafficking of natural killer cells. Immunol Rev 
220:169–182. 
75. Morrison BE, Park SJ, Mooney JM, Mehrad B (2003) Chemokine-mediated 
recruitment of NK cells is a critical host defense mechanism in invasive 
aspergillosis. J Clin Invest 112:1862–1870. 
76. Khan IA et al. (2006) CCR5 Is Essential for NK Cell Trafficking and Host 
Survival following Toxoplasma gondii Infection. PLoS Pathog 2:e49. 
77. Salazar-Mather TP, Lewis CA, Biron CA (2002) Type I interferons regulate 
inflammatory cell trafficking and macrophage inflammatory protein 1$ delivery 
to the liver. Journal of Clinical Investigation 110:321. 
78. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM (2009) Murine 
cytomegalovirus displays selective infection of cells within hours after systemic 
administration. J Gen Virol 90:33–43. 
79. Paust S et al. (2010) Critical role for the chemokine receptor CXCR6 in NK cell–
mediated antigen-specific memory of haptens and viruses. Nat Immunol 
11:1127–1135. 
80. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller M (2007) Induction of 
 181 
Natural Killer Cell Responses by Ectromelia Virus Controls Infection. Journal of 
Virology 81:4070–4079. 
81. Fang M, Lanier LL, Sigal LJ (2008) A Role for NKG2D in NK Cell–Mediated 
Resistance to Poxvirus Disease. PLoS Pathogens 4:e30. 
82. Kennedy M et al. (2000) Reversible defects in natural killer and memory CD8 T 
cell lineages in interleukin 15-deficient mice. J Exp Med 191:771–780. 
83. Fang M et al. (2011) CD94 Is Essential for NK Cell-Mediated Resistance to a 
Lethal Viral Disease. Immunity 34:579–589. 
84. Gillard GO et al. (2011) Thy1+ Nk Cells from Vaccinia Virus-Primed Mice 
Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive 
Lymphocytes. PLoS Pathog 7:e1002141. 
85. Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN (2007) 
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp 
Med 204:1311–1317. 
86. Xue X et al. (2011) Structural Basis of Chemokine Sequestration by CrmD, a 
Poxvirus-Encoded Tumor Necrosis Factor Receptor. PLoS Pathog 7:e1002162. 
87. Epperson ML, Lee CA, Fremont DH (2012) Subversion of cytokine networks by 
virally encoded decoy receptors. Immunol Rev 250:199–215. 
88. Hildner K et al. (2008) Batf3 Deficiency Reveals a Critical Role for CD8 + 
Dendritic Cells in Cytotoxic T Cell Immunity. Science 322:1097–1100. 
89. Joachimiak MP, Weisman JL, May BC (2006) JColorGrid: software for the 
visualization of biological measurements. BMC Bioinformatics 7:225. 
90. Knorr CW, Allen SD, Torres AR, Smee DF (2006) Effects of cidofovir treatment 
on cytokine induction in murine models of cowpox and vaccinia virus infection. 
Antiviral Res 72:125–133. 
91. Begon M et al. (1999) Transmission dynamics of a zoonotic pathogen within and 
between wildlife host species. Proc Biol Sci 266:1939–1945. 
92. Subrahmanyan TP (1968) A study of the possible basis of age-dependent 
resistance of mice to poxvirus diseases. Aust J Exp Biol Med Sci 46:251–265. 
93. Mims CA (1968) The response of mice to the intravenous injection of cowpox 
virus. Br J Exp Pathol 49:24–32. 
94. Andrian Von UH, Mempel TR (2003) Homing and cellular traffic in lymph 
nodes. Nat Rev Immunol 3:867–878. 
95. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage 
subsets. Nat Rev Immunol 11:723–737. 
96. Beauvillain C et al. (2011) CCR7 is involved in the migration of neutrophils to 
lymph nodes. The Journal of Clinical Investigation 117:1196–1204. 
97. Naik SH (2008) Demystifying the development of dendritic cell subtypes, a little. 
Immunol Cell Biol 86:439–452. 
98. Heath W, Carbone F (2009) Dendritic cell subsets in primary and secondary T 
cell responses at body surfaces. Nat Immunol 10:1237–1244. 
99. Forster R et al. (1999) CCR7 coordinates the primary immune response by 
establishing functional microenvironments in secondary lymphoid organs. Cell 
99:23–33. 
100. Seaman WE, Sleisenger M, Eriksson E, Koo GC (1987) Depletion of natural 
killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense 
against malignancy without loss of cellular or humoral immunity. J Immunol 
138:4539–4544. 
 182 
101. Vosshenrich CAJ et al. (2006) A thymic pathway of mouse natural killer cell 
development characterized by expression of GATA-3 and CD127. Nat Immunol 
7:1217–1224. 
102. Vargas CL, Poursine-Laurent J, Yang L, Yokoyama WM (2011) Development of 
thymic NK cells from double negative 1 thymocyte precursors. Blood 118:3570–
3578. 
103. Cella M et al. (2009) A human natural killer cell subset provides an innate source 
of IL-22 for mucosal immunity. Nature 457:722–725. 
104. Groom JR, Luster AD (2011) CXCR3 ligands: redundant, collaborative and 
antagonistic functions. Immunol Cell Biol 89:207–215. 
105. Liu Q, Smith CW, Zhang W, Burns AR, Li Z (2012) NK Cells Modulate the 
Inflammatory Response to Corneal Epithelial Abrasion and Thereby Support 
Wound Healing. Am J Pathol 181:452–462. 
106. Wendel M, Galani IE, Suri-Payer E, Cerwenka A (2008) Natural Killer Cell 
Accumulation in Tumors Is Dependent on IFN-  and CXCR3 Ligands. Cancer 
Research 68:8437–8445. 
107. Martín-Fontecha A et al. (2004) Induced recruitment of NK cells to lymph nodes 
provides IFN-! for TH1 priming. Nat Immunol 5:1260–1265. 
108. Thapa M, Kuziel WA, Carr DJJ (2007) Susceptibility of CCR5-Deficient Mice to 
Genital Herpes Simplex Virus Type 2 Is Linked to NK Cell Mobilization. J Virol 
81:3704–3713. 
109. Gregoire C et al. (2008) Intrasplenic trafficking of natural killer cells is 
redirected by chemokines upon inflammation. Eur J Immunol 38:2076–2084. 
110. Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in 
cancer. Nat Rev Immunol 3:582–591. 
111. Moulton EA, Bertram P, Chen N, Buller RML, Atkinson JP (2010) Ectromelia 
Virus Inhibitor of Complement Enzymes Protects Intracellular Mature Virus and 
Infected Cells from Mouse Complement. J Virol 84:9128–9139. 
112. Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RM (1989) 
Inhibition of an inflammatory response is mediated by a 38-kDa protein of 
cowpox virus. Virology 172:262–273. 
113. Palumbo GJ, Glasgow WC, Buller RM (1993) Poxvirus-induced alteration of 
arachidonate metabolism. Proc Natl Acad Sci USA 90:2020–2024. 
114. Walzer T et al. (2007) Natural killer cell trafficking in vivo requires a dedicated 
sphingosine 1-phosphate receptor. Nat Immunol 8:1337–1344. 
115. Randolph GJ, Ochando J, Partida-Sánchez S (2008) Migration of dendritic cell 
subsets and their precursors. Annu Rev Immunol 26:293–316. 
116. Martin-Fontecha A et al. (2003) Regulation of dendritic cell migration to the 
draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 
198:615–621. 
117. Gerosa F et al. (2002) Reciprocal activating interaction between natural killer 
cells and dendritic cells. J Exp Med 195:327–333. 
118. Bar-On L, Jung S (2010) Defining in vivo dendritic cell functions using CD11c-
DTR transgenic mice. Methods Mol Biol 595:429–442. 
119. Jung S et al. (2002) In vivo depletion of CD11c+ dendritic cells abrogates 
priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 
17:211–220. 
120. Naik SH et al. (2005) Cutting edge: generation of splenic CD8+ and CD8- 
 183 
dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow 
cultures. J Immunol 174:6592–6597. 
121. Jenne L, Hauser C, Arrighi JF, Saurat JH, Hügin AW (2000) Poxvirus as a vector 
to transduce human dendritic cells for immunotherapy: abortive infection but 
reduced APC function. Gene Ther 7:1575–1583. 
122. Winter S et al. (2011) Manifestation of spontaneous and early autoimmune 
gastritis in CCR7-deficient mice. Am J Pathol 179:754–765. 
123. Davalos-Misslitz ACM et al. (2007) Generalized multi-organ autoimmunity in 
CCR7-deficient mice. Eur J Immunol 37:613–622. 
124. Shortman K, Heath WR (2010) The CD8+ dendritic cell subset. Immunol Rev 
234:18–31. 
125. Bedoui S et al. (2009) Cross-presentation of viral and self antigens by skin-
derived CD103+ dendritic cells. Nat Immunol 10:488–495. 
126. Liard C et al. (2012) Intradermal immunization triggers epidermal Langerhans 
cell mobilization required for CD8 T-cell immune responses. J Invest Dermatol 
132:615–625. 
127. Allan RS et al. (2003) Epidermal viral immunity induced by CD8alpha+ 
dendritic cells but not by Langerhans cells. Science 301:1925–1928. 
128. Martin-Fontecha A, Lanzavecchia A, Sallusto F (2009) Dendritic cell migration 
to peripheral lymph nodes. Handb Exp Pharmacol:31–49. 
129. Oussoren C, Storm G (1999) Role of macrophages in the localisation of 
liposomes in lymph nodes after subcutaneous administration. Int J Pharm 
183:37–41. 
130. Junt T et al. (2007) Subcapsular sinus macrophages in lymph nodes clear lymph-
borne viruses and present them to antiviral B cells. Nature 450:110–114. 
131. Kastenmüller W, Torabi-Parizi P, Subramanian N, Lämmermann T, Germain RN 
(2012) A Spatially-Organized Multicellular Innate Immune Response in Lymph 
Nodes Limits Systemic Pathogen Spread. Cell 150:1235–1248. 
132. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW (2002) Visualizing 
priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat 
Immunol 3:265–271. 
133. Probst H et al. (2005) Histological analysis of CD11c-DTR/GFP mice after in 
vivo depletion of dendritic cells. Clin Exp Immunol 141:398–404. 
134. Melchjorsen J (2006) Induction of cytokine expression by herpes simplex virus 
in human monocyte-derived macrophages and dendritic cells is dependent on 
virus replication and is counteracted by ICP27 targeting NF- B and IRF-3. 
Journal of General Virology 87:1099–1108. 
135. Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE (2006) The 
Chemokines CXCL9 and CXCL10 Promote a Protective Immune Response but 
Do Not Contribute to Cardiac Inflammation following Infection with 
Trypanosoma cruzi. Infect Immun 74:125. 
136. Zitvogel L (2002) Dendritic and natural killer cells cooperate in the 
control/switch of innate immunity. J Exp Med 195:F9–14. 
137. Orange JS, Biron CA (1996) Characterization of early IL-12, IFN-alphabeta, and 
TNF effects on antiviral state and NK cell responses during murine 
cytomegalovirus infection. J Immunol 156:4746–4756. 
138. Bennett CL, Clausen BE (2007) DC ablation in mice: promises, pitfalls, and 
challenges. Trends Immunol 28:525–531. 
 184 
139. Coombes JL, Han S-J, van Rooijen N, Raulet DH, Robey EA (2012) Infection-
induced regulation of natural killer cells by macrophages and collagen at the 
lymph node subcapsular sinus. Cell Rep 2:124–135. 
140. Garcia Z et al. (2012) Subcapsular sinus macrophages promote NK cell 
accumulation and activation in response to lymph borne viral particles. The 
Journal of Clinical Investigation. 
141. Tsai WC et al. (2000) CXC chemokine receptor CXCR2 is essential for 
protective innate host response in murine Pseudomonas aeruginosa pneumonia. 
Infect Immun 68:4289–4296. 
142. Eisele NA, Lee-Lewis H, Besch-Williford C, Brown CR, Anderson DM (2011) 
Chemokine Receptor CXCR2 Mediates Bacterial Clearance Rather Than 
Neutrophil Recruitment in a Murine Model of Pneumonic Plague. Am J Pathol 
178:1190–1200. 
143. Herbold W et al. (2010) Importance of CXC Chemokine Receptor 2 in Alveolar 
Neutrophil and Exudate Macrophage Recruitment in Response to Pneumococcal 
Lung Infection. Infect Immun 78:2620–2630. 
144. Rothenberg ME, Hogan SP (2006) The Eosinophil. Annu Rev Immunol 24:147–
174. 
145. Essbauer S, Pfeffer M, Meyer H (2010) Zoonotic poxviruses. Vet Microbiol 
140:229–236. 
146. Dixon H et al. (2006) The role of Th2 cytokines, chemokines and parasite 
products in eosinophil recruitment to the gastrointestinal mucosa during helminth 
infection. Eur J Immunol 36:1753–1763. 
147. Ancuta P et al. (2006) CD16+ monocyte-derived macrophages activate resting T 
cells for HIV infection by producing CCR3 and CCR4 ligands. J Immunol 
176:5760–5771. 
148. Strowig T, Brilot F, Münz C (2008) Noncytotoxic functions of NK cells: direct 
pathogen restriction and assistance to adaptive immunity. J Immunol 180:7785–
7791. 
149. Kishimoto T (2010) IL-6: from its discovery to clinical applications. Int Immunol 
22:347–352. 
150. Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of 
immunity to infection. J Immunol 180:5771–5777. 
151. Sun JC, Lanier LL (2011) NK cell development, homeostasis and function: 
parallels with CD8+ T cells. Nat Rev Immunol 11:645–657. 
152. Kirwan S, Merriam D, Barsby N, McKinnon A, Burshtyn DN (2006) Vaccinia 
virus modulation of natural killer cell function by direct infection. Virology 
347:75–87. 
153. Parker AK, Yokoyama WM, Corbett JA, Chen N, Buller RML (2008) Primary 
naive and interleukin-2-activated natural killer cells do not support efficient 
ectromelia virus replication. Journal of General Virology 89:751–759. 
154. Grütz G (2005) New insights into the molecular mechanism of interleukin-10-
mediated immunosuppression. J Leukoc Biol 77:3–15. 
155. Berg RE, Forman J (2006) The role of CD8 T cells in innate immunity and in 
antigen non-specific protection. Curr Opin Immunol 18:338–343. 
156. A Alcamí GLS (1995) Vaccinia, cowpox, and camelpox viruses encode soluble 
gamma interferon receptors with novel broad species specificity. Journal of 
Virology 69:4633–4639. 
 185 
157. Lisni% VJ, Krmpoti% A, Jonji% S (2010) Modulation of natural killer cell activity 
by viruses. Current Opinion in Microbiology 13:530–539. 
158. Yang Z, Bjorkman PJ (2008) Structure of UL18, a peptide-binding viral MHC 
mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A 
105:10095–10100. 
159. Braud VM et al. (1998) HLA-E binds to natural killer cell receptors 
CD94/NKG2A, B and C. Nature 391:795–799. 
160. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse 
CD94/NKG2A Is a Natural Killer Cell Receptor for  the Nonclassical Major 
Histocompatibility Complex (MHC)  Class I Molecule Qa-1b. The Journal of 
Experimental Medicine 188:1841. 
161. Marquardt N, Wilk E, Pokoyski C, Schmidt RE, Jacobs R (2010) Murine 
CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell 
population. Eur J Immunol 40:1428–1439. 
162. Braun A et al. (2011) Afferent lymph–derived T cells and DCs use different 
chemokine receptor CCR7–dependent routes for entry into the lymph node and 
intranodal migration. Nat Immunol 12:879–887. 
163. Orange JS, Biron CA (1996) An absolute and restricted requirement for IL-12 in 
natural killer cell IFN-gamma production and antiviral defense. Studies of 
natural killer and T cell responses in contrasting viral infections. J Immunol 
156:1138–1142. 
164. Akira S (2000) The role of IL-18 in innate immunity. Curr Opin Immunol 12:59–
63. 
165. Brandstadter JD, Yang Y (2011) Natural killer cell responses to viral infection. J 
Innate Immun 3:274–279. 
166. Fehniger TA et al. (1999) Differential cytokine and chemokine gene expression 
by human NK cells following activation with IL-18 or IL-15 in combination with 
IL-12: implications for the innate immune response. J Immunol 162:4511–4520. 
167. Seidel E, Glasner A, Mandelboim O (2012) Virus-mediated inhibition of natural 
cytotoxicity receptor recognition. Cell Mol Life Sci. 
168. Chisholm SE, Reyburn HT (2006) Recognition of vaccinia virus-infected cells 
by human natural killer cells depends on natural cytotoxicity receptors. J Virol 
80:2225–2233. 
169. Jarahian M et al. (2011) Modulation of NKp30- and NKp46-Mediated Natural 
Killer Cell Responses by Poxviral Hemagglutinin. PLoS Pathog 7:e1002195. 
 
 
